• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Babcock & Wilcox Enterprises Inc.

    5/12/25 4:40:34 PM ET
    $BW
    Building Products
    Industrials
    Get the next $BW alert in real time by email
    bw-20250331
    false2025Q1000163080512/3191xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:DKKxbrli:purebw:segment00016308052025-01-012025-03-310001630805us-gaap:CommonStockMember2025-01-012025-03-310001630805bw:SeniorNotes8125Due2026Member2025-01-012025-03-310001630805bw:SeniorNotes650Due2026Member2025-01-012025-03-310001630805us-gaap:SeriesAPreferredStockMember2025-01-012025-03-3100016308052025-05-0500016308052024-01-012024-03-3100016308052025-03-3100016308052024-12-3100016308052024-03-310001630805us-gaap:CommonStockMember2024-12-310001630805us-gaap:PreferredStockMember2024-12-310001630805us-gaap:AdditionalPaidInCapitalMember2024-12-310001630805us-gaap:TreasuryStockCommonMember2024-12-310001630805us-gaap:RetainedEarningsMember2024-12-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001630805us-gaap:NoncontrollingInterestMember2024-12-310001630805us-gaap:RetainedEarningsMember2025-01-012025-03-310001630805us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001630805us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001630805us-gaap:CommonStockMember2025-01-012025-03-310001630805us-gaap:CommonStockMember2025-03-310001630805us-gaap:PreferredStockMember2025-03-310001630805us-gaap:AdditionalPaidInCapitalMember2025-03-310001630805us-gaap:TreasuryStockCommonMember2025-03-310001630805us-gaap:RetainedEarningsMember2025-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001630805us-gaap:NoncontrollingInterestMember2025-03-310001630805us-gaap:CommonStockMember2023-12-310001630805us-gaap:PreferredStockMember2023-12-310001630805us-gaap:AdditionalPaidInCapitalMember2023-12-310001630805us-gaap:TreasuryStockCommonMember2023-12-310001630805us-gaap:RetainedEarningsMember2023-12-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001630805us-gaap:NoncontrollingInterestMember2023-12-3100016308052023-12-310001630805us-gaap:RetainedEarningsMember2024-01-012024-03-310001630805us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001630805us-gaap:CommonStockMember2024-01-012024-03-310001630805us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001630805us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001630805us-gaap:CommonStockMember2024-03-310001630805us-gaap:PreferredStockMember2024-03-310001630805us-gaap:AdditionalPaidInCapitalMember2024-03-310001630805us-gaap:TreasuryStockCommonMember2024-03-310001630805us-gaap:RetainedEarningsMember2024-03-310001630805us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001630805us-gaap:NoncontrollingInterestMember2024-03-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-310001630805us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-03-310001630805bw:SeniorNotes8125Due2026Memberus-gaap:SeniorNotesMember2025-03-310001630805bw:VlundMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2025-04-292025-04-290001630805bw:VlundMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2025-04-290001630805us-gaap:RelatedPartyMemberus-gaap:SubsequentEventMember2025-04-290001630805bw:AtTheMarketOfferingMember2025-03-312025-03-310001630805bw:AtTheMarketOfferingMember2024-12-312024-12-3100016308052025-03-312025-03-3100016308052024-12-312024-12-310001630805bw:SeniorNotes650Due2026Memberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-05-080001630805bw:SeniorNotes8125Due2026Memberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-05-080001630805bw:A8.75SeniorSecuredSecondLienNotesDue2030Memberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-05-080001630805us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbw:BabcockWilcoxRenewableServiceASBWRSMember2024-06-282024-06-280001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BabcockWilcoxRenewableServiceASBWRSMember2025-01-012025-03-310001630805us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbw:SPIGAndGMABMember2024-10-302024-10-300001630805us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbw:SPIGMember2024-07-012024-09-300001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BWSolarMember2025-01-012025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:VlundMember2025-01-012025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMember2025-01-012025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BWSolarMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BabcockWilcoxRenewableServiceASBWRSMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:SPIGMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:GMABMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:VlundMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMember2024-01-012024-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BWSolarMember2025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:VlundMember2025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMember2025-03-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:BWSolarMember2024-12-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMemberbw:VlundMember2024-12-310001630805us-gaap:DiscontinuedOperationsHeldforsaleMember2024-12-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWRenewableSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWRenewableSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWRenewableSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWRenewableSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberus-gaap:ConstructionMemberbw:BWRenewableSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberus-gaap:ConstructionMemberbw:BWRenewableSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWRenewableSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWRenewableSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWEnvironmentalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWEnvironmentalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWEnvironmentalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWEnvironmentalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWEnvironmentalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWEnvironmentalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWThermalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:PartsMemberbw:BWThermalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWThermalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:ProjectsMemberbw:BWThermalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberus-gaap:ConstructionMemberbw:BWThermalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberus-gaap:ConstructionMemberbw:BWThermalSegmentMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWThermalSegmentMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMemberbw:BWThermalSegmentMember2024-01-012024-03-310001630805us-gaap:IntersegmentEliminationMember2025-01-012025-03-310001630805us-gaap:IntersegmentEliminationMember2024-01-012024-03-310001630805us-gaap:OperatingSegmentsMember2025-01-012025-03-310001630805us-gaap:OperatingSegmentsMember2024-01-012024-03-310001630805us-gaap:TransferredAtPointInTimeMember2025-01-012025-03-310001630805us-gaap:TransferredAtPointInTimeMember2024-01-012024-03-310001630805us-gaap:TransferredOverTimeMember2025-01-012025-03-310001630805us-gaap:TransferredOverTimeMember2024-01-012024-03-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2025-03-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2024-12-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2025-01-012025-03-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2025-03-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2024-12-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2025-01-012025-03-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2025-03-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2024-12-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2025-01-012025-03-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2025-03-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2024-12-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2025-01-012025-03-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2024-03-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2023-12-310001630805bw:CostIncurredLessCostsOfRevenueRecognizedMember2024-01-012024-03-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2024-03-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2023-12-310001630805bw:RevenuesRecognizedLessBillingsToCustomersMember2024-01-012024-03-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2024-03-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2023-12-310001630805bw:BillingsToCustomersLessRevenuesRecognizedMember2024-01-012024-03-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2024-03-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2023-12-310001630805bw:CostsOfRevenueRecognizedLessCostIncurredMember2024-01-012024-03-3100016308052025-04-012025-03-3100016308052026-01-012025-03-3100016308052027-01-012025-03-310001630805us-gaap:LandMember2025-03-310001630805us-gaap:LandMember2024-12-310001630805us-gaap:BuildingMember2025-03-310001630805us-gaap:BuildingMember2024-12-310001630805us-gaap:MachineryAndEquipmentMember2025-03-310001630805us-gaap:MachineryAndEquipmentMember2024-12-310001630805us-gaap:ConstructionInProgressMember2025-03-310001630805us-gaap:ConstructionInProgressMember2024-12-310001630805bw:BWRenewableSegmentMember2024-12-310001630805bw:BWEnvironmentalSegmentMember2024-12-310001630805bw:BWThermalSegmentMember2024-12-310001630805bw:BWRenewableSegmentMember2025-01-012025-03-310001630805bw:BWEnvironmentalSegmentMember2025-01-012025-03-310001630805bw:BWThermalSegmentMember2025-01-012025-03-310001630805bw:BWRenewableSegmentMember2025-03-310001630805bw:BWEnvironmentalSegmentMember2025-03-310001630805bw:BWThermalSegmentMember2025-03-310001630805us-gaap:CustomerRelationshipsMember2025-03-310001630805us-gaap:CustomerRelationshipsMember2024-12-310001630805us-gaap:UnpatentedTechnologyMember2025-03-310001630805us-gaap:UnpatentedTechnologyMember2024-12-310001630805us-gaap:PatentedTechnologyMember2025-03-310001630805us-gaap:PatentedTechnologyMember2024-12-310001630805us-gaap:TradeNamesMember2025-03-310001630805us-gaap:TradeNamesMember2024-12-310001630805us-gaap:OtherIntangibleAssetsMember2025-03-310001630805us-gaap:OtherIntangibleAssetsMember2024-12-310001630805us-gaap:TrademarksAndTradeNamesMember2025-03-310001630805us-gaap:TrademarksAndTradeNamesMember2024-12-310001630805us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-03-310001630805us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-03-310001630805us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310001630805bw:SeniorNotes650Due2026Memberus-gaap:SeniorNotesMember2025-03-310001630805us-gaap:SeniorNotesMember2025-03-310001630805bw:SeniorNotes8125Due2026Memberus-gaap:SeniorNotesMember2024-12-310001630805bw:SeniorNotes650Due2026Memberus-gaap:SeniorNotesMember2024-12-310001630805us-gaap:SeniorNotesMember2024-12-310001630805bw:CreditFacilityMemberus-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2024-01-310001630805us-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2024-01-310001630805bw:DebtInstrumentCovenantOneMemberbw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-01-310001630805bw:DebtInstrumentCovenantOneMemberbw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-310001630805bw:DebtInstrumentCovenantTwoMemberbw:CreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-01-310001630805bw:DebtInstrumentCovenantTwoMemberbw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:FederalFundsEffectiveSwapRateMember2024-01-012024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberbw:DailySimpleSecuredOvernightFinancingRateSOFRMember2024-01-012024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2025-03-250001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2025-03-310001630805bw:CreditFacilityMemberus-gaap:LetterOfCreditMember2025-03-310001630805bw:CreditFacilityMember2025-03-310001630805bw:SaleLeasebackFinancingTransactionsMember2025-03-310001630805bw:SaleLeasebackFinancingTransactionsMember2024-12-310001630805us-gaap:LetterOfCreditMember2021-06-300001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-03-310001630805bw:PerformanceLettersOfCreditMember2025-03-310001630805bw:PerformanceLettersOfCreditMember2024-03-310001630805bw:FinancialLettersOfCreditMember2025-03-310001630805bw:FinancialLettersOfCreditMember2024-03-310001630805bw:BackstoppedBondsMember2025-03-310001630805bw:BackstoppedBondsMember2024-03-310001630805us-gaap:SuretyBondMember2025-03-310001630805us-gaap:SuretyBondMember2024-03-310001630805bw:LettersOfCreditSubjectToForeignCurrencyRevaluationMember2025-03-310001630805bw:LettersOfCreditSubjectToForeignCurrencyRevaluationMember2024-03-310001630805bw:LetterOfCreditNonDomesticFacilitiesMember2025-03-310001630805bw:LetterOfCreditNonDomesticFacilitiesMember2024-03-310001630805us-gaap:SeniorNotesMember2025-01-012025-03-310001630805us-gaap:SeniorNotesMember2024-01-012024-03-310001630805us-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310001630805us-gaap:RevolvingCreditFacilityMember2024-01-012024-03-310001630805us-gaap:SeriesAPreferredStockMember2025-03-310001630805bw:B.RileyFinancialInc.Membersrt:AffiliatedEntityMember2024-04-100001630805bw:CashandCashEquivalentsForeignOperationsMember2025-03-310001630805bw:CashandCashEquivalentsForeignOperationsMember2024-12-310001630805country:US2025-03-310001630805country:US2024-12-310001630805bw:CashHeldToMeetReinsuranceReserveRequirementsMember2025-03-310001630805bw:CashHeldToMeetReinsuranceReserveRequirementsMember2024-12-310001630805bw:ProjectIndemnityCollateralMember2025-03-310001630805bw:ProjectIndemnityCollateralMember2024-12-310001630805bw:LettersOfCreditCollateralMember2025-03-310001630805bw:LettersOfCreditCollateralMember2024-12-310001630805bw:EscrowMember2025-03-310001630805bw:EscrowMember2024-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001630805us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001630805us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001630805us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001630805us-gaap:CommercialPaperMember2025-03-310001630805us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2025-03-310001630805us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310001630805us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-03-310001630805us-gaap:FairValueInputsLevel1Member2025-03-310001630805us-gaap:CommercialPaperMember2024-12-310001630805us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2024-12-310001630805us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310001630805us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310001630805us-gaap:FairValueInputsLevel1Member2024-12-310001630805srt:MinimumMember2025-03-310001630805srt:MaximumMember2025-03-310001630805bw:BabcockWilcoxEnterprisesInc.Memberbw:B.RileyCapitalManagementLLCMember2025-01-012025-03-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberbw:AnnualFeeMember2024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberbw:AnnualFeeMember2024-01-012024-01-310001630805bw:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberbw:BPRIExecutiveConsultingLLCMemberbw:AnnualFeeMember2024-01-012024-01-310001630805srt:AffiliatedEntityMemberbw:BRileySecuritiesIncMember2024-04-300001630805srt:AffiliatedEntityMemberbw:BPRIExecutiveConsultingLLCMemberbw:FinancialAdvisoryServicesMember2018-11-012018-11-300001630805srt:AffiliatedEntityMemberbw:BPRIExecutiveConsultingLLCMemberbw:FinancialAdvisoryServicesMember2025-01-012025-03-310001630805srt:AffiliatedEntityMemberbw:BPRIExecutiveConsultingLLCMemberbw:FinancialAdvisoryServicesMember2024-01-012024-03-310001630805srt:AffiliatedEntityMemberbw:BPRIExecutiveConsultingLLCMemberbw:FinancialAdvisoryServicesMember2024-12-12

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 10-Q
    (Mark One)
    ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended March 31, 2025

    OR
    ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from                      to                     

    Commission File No. 001-36876 

    BABCOCK & WILCOX ENTERPRISES, INC.
    (Exact name of registrant as specified in its charter)
    Delaware 47-2783641
    (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
    1200 East Market Street, Suite 650
     
    Akron, Ohio
     44305
    (Address of Principal Executive Offices) (Zip Code)
    Registrant's Telephone Number, Including Area Code: (330) 753-4511
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $0.01 par valueBWNew York Stock Exchange
    8.125% Senior Notes due 2026BWSNNew York Stock Exchange
    6.50% Senior Notes due 2026BWNBNew York Stock Exchange
    7.75% Series A Cumulative Perpetual Preferred StockBW PRANew York Stock Exchange
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  ☒    No  ☐
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
    Large accelerated filer ☐  Accelerated filer ☒
    Non-accelerated filer ☐  Smaller reporting company 
    ☐
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    
    Yes  ☐    No  ☒
    The number of shares of the registrant's common stock outstanding at May 5, 2025 was 98,404,024.
    1


    TABLE OF CONTENTS
     PAGE
    Cautionary Statement Concerning Forward-Looking Information
    4
    PART I - FINANCIAL INFORMATION
    Item 1.
    Condensed Consolidated Financial Statements
    5
    Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 (Unaudited)
    6
    Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three Months Ended March 31, 2025 and 2024 (Unaudited)
    7
    Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024 (Unaudited)
    8
    Condensed Consolidated Statements of Stockholders' (Deficit) Equity for the Three Months Ended March 31, 2025 and 2024 (Unaudited)
    9
    Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 (Unaudited)
    10
    Notes to Condensed Consolidated Financial Statements
    12
    Item 2.
    Management's Discussion and Analysis of Financial Condition and Results of Operation
    35
    Overview
    35
    Results of Operations - Three Months Ended March 31, 2025 and 2024
    36
    Liquidity and Capital Resources
    44
    Critical Accounting Policies and Estimates
    45
    Item 3.
    Quantitative and Qualitative Disclosures about Market Risk
    45
    Item 4.
    Controls and Procedures
    45
    PART II - OTHER INFORMATION
    Item 1.
    Legal Proceedings
    47
    Item 1A.
    Risk Factors
    47
    Item 2.
    Unregistered Sales of Equity Securities and Use of Proceeds
    47
    Item 5.
    Other Information
    47
    Item 6.
    Exhibits
    48
    SIGNATURES
    49
    2


    Definitions

    In this Quarterly Report on Form 10-Q, or this "Quarterly Report", unless the context otherwise indicates, "B&W," "we," "us," "our" or the "Company" mean Babcock & Wilcox Enterprises, Inc. and its consolidated subsidiaries. Unless otherwise noted, discussion of our business and results of operations in this Quarterly Report on Form 10-Q refers to our continuing operations.
    Abbreviation or acronymTerm
    6.50% Senior Notes6.50% Senior Notes due December 31, 2026 issued by Babcock & Wilcox Enterprises, Inc. in 2021
    8.125% Senior Notes8.125% Senior Notes due February 28, 2026 issued by Babcock & Wilcox Enterprises, Inc. in 2021
    AgentsCollectively, B. Riley Securities, Inc., Seaport Global Securities LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC
    AOCIAccumulated Other Comprehensive Income (loss)
    ASCAccounting Standards Codification
    ASUAccounting Standards Update
    At-The-Market offeringThe offer and sale from time to time of shares of our common stock, having an aggregate offering price of up to $50.0 million
    AxosAxos Bank, an affiliate of Axos Financial, Inc.
    B&W SolarBabcock & Wilcox Solar Energy, Inc., formerly known as Fosler Construction Company, Inc.
    B. RileyB. Riley Financial, Inc and its affiliates, a related party
    BWRSBabcock & Wilcox Renewable Service A/S
    CODMChief Operating Decision Maker
    Credit AgreementCredit Agreement between us, with certain of our subsidiaries as guarantors, the lenders party thereto from time to time and Axos Bank, as administrative agent, swingline lender and letter of credit issuer on January, 18, 2024 (as amended from time to time).
    Credit FacilityRevolving credit facility
    CTACurrency translation adjustment
    Debt FacilitiesCollectively, the Revolving Credit Agreement and Letter of Credit Agreement
    Disposal GroupAssets and liabilities that are held for sale as part of B&W Solar
    EBITDAEarnings before interest, taxes, depreciation and amortization
    Exchange ActThe Securities Exchange Act of 1934, as amended
    FASBFinancial Accounting Standards Board
    Fourth AmendmentFourth Amendment to the Credit Agreement
    GAAPGenerally Accepted Accounting Principles in the United States of America
    GlatfelterP.H. Glatfelter Company
    GMABBabcock & Wilcox Vølund AB f/k/a Gӧtaverken Miljӧ AB
    Letter of Credit AgreementLetter of Credit agreement with PNC
    MSDMSD Partners and affiliates, including MSD PCOF Partners XLV, LLC
    MTMMark-to-Market
    Notes Due 2026Collectively, the 8.125% Senior Notes due February 28, 2026 and the 6.50% Senior Notes due December 31, 2026
    Over timeRefers to fixed long-term pricing in contract term revenue
    PBGCPension Benefit Guaranty Corporation
    PlaintiffA B&W stockholder
    PNCPNC Bank, National Association
    Preferred Stock7.75% Series A Cumulative Perpetual Preferred Stock
    Registration Rights AgreementRegistration rights agreement with B. Riley
    Sales AgreementSales agreement with B. Riley Securities, Inc., Seaport Global Securities LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC
    SECUnited States Securities and Exchange Commission
    3


    Abbreviation or acronymTerm
    Securities ActThe Securities Act of 1933, as amended
    SG&ASelling, general and administrative expenses
    SOFRThe Secured Overnight Financing Rate
    SPIGSPIG S.p.A
    U.S. PlanRetirement Plan for Employees of Babcock & Wilcox Commercial Operations

    ***** Cautionary Statement Concerning Forward-Looking Information *****

    This Quarterly Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical or current fact included in this Quarterly Report are forward-looking statements. You should not place undue reliance on these statements. Forward-looking statements include words such as "expect," "intend," "plan," "likely," "seek," "believe," "project," "forecast," "target," "goal," "potential," "estimate," "may," "might," "will," "would," "should," "could," "can," "have," "due," "anticipate," "assume," "contemplate," "continue" and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operational performance or other events.

    The forward-looking statements included herein are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as required by law. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, but not limited to: that our financial condition raises substantial doubt as to our ability to continue as a going concern and we have entered into a number of amendments and waivers to our Debt Facilities; our need of additional financing to continue as a going concern; any negative reactions to the substantial doubt about our ability to continue as a going concern by our customers, suppliers, vendors, employees and other third parties; risks associated with contractual pricing in our industry; our relationships with customers, subcontractors and other third parties; our ability to comply with our contractual obligations; disruptions at our manufacturing facilities or a third-party manufacturing facility that we have engaged; the actions or failures of our co-venturers; our ability to implement our growth strategy, including through strategic acquisitions, which we may not successfully consummate or integrate; our evaluation of strategic alternatives for certain businesses and non-core assets may not result in a successful transaction; the risks of unexpected adjustments and cancellations in our backlog; professional liability, product liability, warranty and other claims; our ability to compete successfully against current and future competitors; our ability to develop and successfully market new products; the impacts of macroeconomic downturns, industry conditions and public health crises; the cyclical nature of the industries in which we operate; changes in the legislative and regulatory environment in which we operate; supply chain issues, including shortages of adequate components; failure to properly estimate customer demand; our ability to comply with the covenants in our debt agreements; our ability to refinance our 8.125% Notes due 2026 and 6.50% Notes due 2026 prior to their maturity; our ability to maintain adequate bonding and letter of credit capacity; impairment of goodwill or other indefinite-lived intangible assets; credit risk; disruptions in, or failures of, our information systems; our ability to comply with privacy and information security laws; our ability to protect our intellectual property and use the intellectual property that we license from third parties; risks related to our international operations, including fluctuations in the value of foreign currencies, current and future changes to global tariffs, sanctions and export controls that could harm our profitability; volatility in the price of our common stock; B. Riley’s significant influence over us; changes in tax rates or tax law; our ability to use net operating loss and certain tax credits; our ability to maintain effective internal control over financial reporting; our ability to attract and retain skilled personnel and senior management; labor problems, including negotiations with labor unions and possible work stoppages; risks associated with our retirement benefit plans; natural disasters or other events beyond our control, such as war, armed conflicts or terrorist attacks; and the risks and uncertainties described under the heading "Risk Factors" in Part I, Item 1A of our Annual Report, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the SEC.

    These forward-looking statements are made based upon detailed assumptions and reflect management's current expectations and beliefs. While we believe that these assumptions underlying the forward-looking statements are reasonable, forward-looking statements are subject to uncertainties and factors relating to our operations and business environment that are difficult to predict and may be beyond our control. Such uncertainties and factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements.

    4


    The forward-looking statements included herein are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as required by law.

    PART I

    ITEM 1. Condensed Consolidated Financial Statements
    5


    BABCOCK & WILCOX ENTERPRISES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (Unaudited)
    Three Months Ended March 31,
    (in thousands, except per share amounts)20252024
    Revenues$181,194 $164,288 
    Costs and expenses:
    Cost of operations141,133 125,534 
    Selling, general and administrative expenses32,727 32,217 
    Research and development costs
    526 815 
    Impairment of long-lived assets950 — 
    Loss on asset disposals, net
    8 — 
    Total costs and expenses175,344 158,566 
    Operating income
    5,850 5,722 
    Other (expense) income:
    Interest expense(11,163)(12,014)
    Interest income228 118 
    Loss on debt extinguishment
    — (5,071)
    Benefit plans, net(753)96 
    Foreign exchange261 (716)
    Other income (expense) – net
    136 (23)
    Total other expense
    (11,291)(17,610)
    Loss from continuing operations before income tax expense
    (5,441)(11,888)
    Income tax expense
    2,322 907 
    Loss from continuing operations
    (7,763)(12,795)
    Loss from discontinued operations, net of tax
    (14,226)(3,996)
    Net loss
    (21,989)(16,791)
    Net loss attributable to non-controlling interest
    (18)(42)
    Net loss attributable to stockholders
    (22,007)(16,833)
    Less: Dividend on Series A preferred stock3,715 3,714 
    Net loss attributable to stockholders of common stock
    $(25,722)$(20,547)
    Basic and diluted loss per share
    Continuing operations$(0.11)$(0.19)
    Discontinued operations(0.15)(0.04)
    Basic and diluted loss per share
    $(0.26)$(0.23)
    Shares used in the computation of loss per share:
    Basic and diluted97,930 89,479 

    See accompanying notes to the Condensed Consolidated Financial Statements.
    6


    BABCOCK & WILCOX ENTERPRISES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
    (Unaudited)
    Three Months Ended March 31,
    (in thousands)20252024
    Net loss
    $(21,989)$(16,791)
    Other comprehensive income (loss):
    Currency translation adjustments403 (3,125)
    Benefit obligations:
    Pension and post retirement adjustments, net of tax124 231 
    Other comprehensive income (loss)
    527 (2,894)
    Total comprehensive loss
    (21,462)(19,685)
    Comprehensive (income) loss attributable to non-controlling interest
    (22)67 
    Comprehensive loss attributable to stockholders
    $(21,484)$(19,618)
    See accompanying notes to the Condensed Consolidated Financial Statements.
    7


    BABCOCK & WILCOX ENTERPRISES, INC.
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (Unaudited)
    (in thousands, except per share amount)March 31, 2025December 31, 2024
    Cash and cash equivalents$21,628 $23,399 
    Current restricted cash84,990 94,167 
    Accounts receivable – trade, net of allowance for credit losses of $1.7 million and $1.8 million as of March 31, 2025 and December 31, 2024, respectively
    128,255 112,677 
    Contracts in progress65,646 82,403 
    Inventories, net111,485 108,889 
    Other current assets28,544 25,096 
    Current assets held for sale42,330 43,554 
    Total current assets482,878 490,185 
    Net property, plant and equipment and finance leases71,171 69,593 
    Goodwill82,495 82,138 
    Intangible assets, net18,418 19,051 
    Right-of-use assets31,817 32,789 
    Long-term restricted cash10,138 10,042 
    Deferred tax assets100 41 
    Other assets22,696 23,148 
    Total assets$719,713 $726,987 
    Accounts payable$119,097 $101,025 
    Accrued employee benefits4,688 4,859 
    Advance billings on contracts53,636 58,478 
    Accrued warranty expense3,395 3,446 
    Financing lease liabilities1,705 1,644 
    Operating lease liabilities3,281 3,550 
    Other accrued liabilities40,617 35,958 
    Current senior notes108,358 — 
    Current borrowings124,168 125,137 
    Current liabilities held for sale52,269 54,396 
    Total current liabilities511,214 388,493 
    Senior notes, net of current portion232,525 340,227 
    Borrowings, net of current portion8,529 8,556 
    Pension and other postretirement benefit liabilities189,516 192,665 
    Finance lease liabilities, net of current portion28,055 28,501 
    Operating lease liabilities, net of current portion29,522 30,315 
    Deferred tax liability12,231 11,028 
    Other noncurrent liabilities10,637 10,374 
    Total liabilities1,022,229 1,010,159 
    Stockholders' deficit:
    Preferred stock, par value $0.01 per share, authorized shares of 20,000; issued and outstanding shares of 7,669 at March 31, 2025 and December 31, 2024
    77 77 
    Common stock, par value $0.01 per share, authorized shares of 500,000; outstanding shares of 98,404 and 95,138 at March 31, 2025 and December 31, 2024, respectively
    5,240 5,208 
    Capital in excess of par value1,564,743 1,558,828 
    Treasury stock at cost, 2,379 and 2,379 shares at March 31, 2025 and December 31, 2024, respectively
    (115,500)(115,500)
    Accumulated deficit(1,671,438)(1,645,716)
    Accumulated other comprehensive loss(86,133)(86,660)
    Stockholders' deficit attributable to shareholders(303,011)(283,763)
    Non-controlling interest495 591 
    Total stockholders' deficit(302,516)(283,172)
    Total liabilities and stockholders' deficit$719,713 $726,987 
    See accompanying notes to the Condensed Consolidated Financial Statements.




























    8


    BABCOCK & WILCOX ENTERPRISES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
    (Unaudited)

    Common StockPreferred StockCapital In
    Excess of
    Par Value
    Treasury StockAccumulated DeficitAccumulated
    Other
    Comprehensive
    (Loss)
    Non-controlling
    Interest
    Total
    Stockholders’
     (Deficit) Equity
    (in thousands)SharesPar
     Value
    SharesPar Value
    Balance at December 31, 2024
    95,138 $5,208 7,669 $77 $1,558,828 $(115,500)$(1,645,716)$(86,660)$591 $(283,172)
    Net loss— — — — — — (22,007)— 18 (21,989)
    Currency translation adjustments— — — — — — — 403 4 407 
    Pension and post retirement adjustments, net of tax— — — — — — — 124 — 124 
    Stock-based compensation charges— — — — 760 — — — — 760 
    Dividends to preferred stockholders— — — — — — (3,715)— — (3,715)
    Common stock offering, net3,266 32 — — 5,155 — — — — 5,187 
    Dividends to non-controlling interest— — — — — — — — (118)(118)
    Balance at March 31, 2025
    98,404 $5,240 7,669 $77 $1,564,743 $(115,500)$(1,671,438)$(86,133)$495 $(302,516)



    Common StockPreferred StockCapital In
    Excess of
    Par Value
    Treasury StockAccumulated DeficitAccumulated
    Other
    Comprehensive
    (Loss)
    Non-controlling
    Interest
    Total
    Stockholders’
    (Deficit) Equity
    (in thousands)SharesPar 
    Value
    SharesPar 
    Value
    Balance at December 31, 2023
    89,449 $5,148 7,669 $77 $1,546,281 $(115,164)$(1,570,942)$(66,361)$611 $(200,350)
    Net loss— — — — — (16,833)— 42 (16,791)
    Currency translation adjustments— — — — — — — (3,125)(109)(3,234)
    Pension and post retirement adjustments, net of tax— — — — — — — 231 — 231 
    Stock-based compensation charges31 1 — — 1,390 — — — — 1,391 
    Dividends to preferred stockholders— — — — — — (3,714)— — (3,714)
    Balance at March 31, 2024
    89,480 $5,149 7,669 $77 $1,547,671 $(115,164)$(1,591,489)$(69,255)$544 $(222,467)

    See accompanying notes to the Condensed Consolidated Financial Statements.
    9


    BABCOCK & WILCOX ENTERPRISES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (Unaudited)

    Three Months Ended March 31,
    (in thousands)20252024
    Operating Activities:
    Net loss from continuing operations
    (7,763)(12,795)
    Net loss from discontinued operations
    (14,226)(3,996)
    Net loss
    $(21,989)$(16,791)
    Adjustments to reconcile net loss to net cash used in operating activities:
    Depreciation and amortization of long-lived assets2,476 4,843 
    Impairment of long-lived assets8,783 — 
    Amortization of deferred financing costs and debt discount1,515 740 
    Amortization of guaranty fee— 608 
    Non-cash operating lease expense1,710 1,804 
    Loss on debt extinguishment— 5,071 
    Loss on asset disposals8 81 
    (Benefit from) provision for deferred income taxes
    (531)2,514 
    Prior service cost amortization for pension and postretirement plans124 231 
    Stock-based compensation760 1,391 
    Foreign exchange (1,781)1,333 
    Unrealized loss on securities
    (544)— 
    Bad debt expense632 1,148 
    Changes in operating assets and liabilities:
    Accounts receivable - trade, net(14,306)16,849 
    Contracts in progress 10,997 (21,515)
    Other current and noncurrent assets(5,658)2,429 
    Advance billings on contracts(7,526)(6,350)
    Inventories, net(2,957)3,100 
    Income taxes253 2,889 
    Accounts payable19,577 (1,758)
    Accrued and other current liabilities8,884 (8,351)
    Accrued contract loss(3,472)(2,784)
    Pension liabilities, accrued postretirement benefits and employee benefits(3,571)176 
    Other, net(1,861)(2,596)
    Net cash used in operating activities:
    (8,477)(14,938)
    Investing Activities:
    Purchase of property, plant and equipment(4,328)(3,394)
    Purchases of securities(3,994)(1,624)
    Sales and maturities of securities4,416 2,147 
    Other, net— 22 
    Net cash used in investing activities
    (3,906)(2,849)


    10


    Three Months Ended March 31,
    (in thousands)20252024
    Financing Activities:
    Borrowings on loan payable18,992 90,352 
    Repayments on loan payable(20,371)(28,802)
    Payment of holdback funds from acquisition— (2,950)
    Finance lease payments(401)(332)
    Payment of preferred stock dividends(3,715)(3,714)
    Issuance of common stock, net5,187 — 
    Payment of non-controlling interest dividends(118)— 
    Debt issuance costs— (3,146)
    Other, net12 (111)
    Net cash (used in) provided by financing activities
    (414)51,297 
    Effects of exchange rate changes on cash352 (2,427)
    Net (decrease) increase in cash, cash equivalents and restricted cash
    (12,445)31,083 
    Cash, cash equivalents and restricted cash at beginning of period131,064 71,369 
    Cash, cash equivalents and restricted cash at end of period$118,619 $102,452 
    Schedule of cash, cash equivalents and restricted cash:
    Cash and cash equivalents$23,491 $43,881 
    Current restricted cash84,990 16,935 
    Long-term restricted cash10,138 41,636 
    Total cash, cash equivalents and restricted cash at end of period (1)
    $118,619 $102,452 
    Supplemental cash flow information:
    Income taxes paid, net$2,533 $2,318 
    Interest paid$9,284 $7,089 
    (1) Includes cash held at discontinued operations of $1.9 million and $12.9 million at March 31, 2025 and 2024, respectively.
    See accompanying notes to the Condensed Consolidated Financial Statements.
    11


    BABCOCK & WILCOX ENTERPRISES, INC.
    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    MARCH 31, 2025

    NOTE 1 – BASIS OF PRESENTATION

    These interim Condensed Consolidated Financial Statements of Babcock & Wilcox Enterprises, Inc. ("B&W," "management," "we," "us," "our" or the "Company") have been prepared in accordance with GAAP and SEC instructions for interim financial information and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2024. The Notes to the Condensed Consolidated Financial Statements are presented on the basis of continuing operations, unless otherwise stated.

    The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. In the opinion of management, these Condensed Consolidated Financial Statements contain all estimates and adjustments, consisting of normal recurring adjustments, required to fairly present the financial position, results of operations, and cash flows for the periods presented. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the full-year ending December 31, 2025.

    There have been no material changes to our significant accounting policies included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

    Non-controlling interests are presented in the Condensed Consolidated Financial Statements as if parent company investors (controlling interests) and other minority investors (non-controlling interests) in partially-owned subsidiaries have similar economic interests in a single entity. As a result, investments in non-controlling interests are reported as equity in the Condensed Consolidated Financial Statements. Additionally, the Condensed Consolidated Financial Statements include 100% of a controlled subsidiary’s earnings, rather than only our share. Transactions between the parent company and non-controlling interests are reported in equity as transactions between stockholders, provided that these transactions do not create a change in control.

    Liquidity and Going Concern

    The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company's ability to continue as a going concern exists.

    We have a credit agreement that provides for an up to $150.0 million asset-based credit facility with an outstanding balance of $123.4 million at March 31, 2025 that is currently due in November 2025 and, accordingly, is classified as a current liability. In addition, we have senior notes due in February 2026 of which $108.4 million is reflected in current liabilities and $83.5 million in noncurrent liabilities in the Condensed Consolidated Balance Sheets. As a result, the uncertainty regarding our ability to repay the current debt raises substantial doubt about our ability to continue as a going concern.

    In response to the conditions that raised substantial doubt about our ability to continue as a going concern, we began implementing several strategies to obtain the required funding for future operations and have considered other alternative measures to improve cash flow, including:

    •sold our Vølund business on April 29, 2025 for a total of $20.1 million in proceeds, which is comprised of a base purchase price equal to $15.0 million plus 400,000 Danish krone and a $5.0 million loan (described in Note 20 of the Condensed Consolidated Financial Statements);
    •sold 3.3 million and 5.0 million common shares for net proceeds of $5.2 million and $7.9 million as of March 31, 2025 and December 31, 2024, respectively, pursuant to our At-The-Market offering (described in Note 13 to the Condensed Consolidated Financial Statements);
    •actively negotiating with holders of the Senior Notes to extend their maturity date. We have entered into privately negotiated exchanges with a limited number of noteholders that will result in $47.8 million aggregate principal amount of the Company's 6.50% Senior Notes due 2026 and $84.0 million aggregate principal amount of the Company's 8.125% Senior Notes due 2026 being exchanged for $100.8 million aggregate principal amount of
    12


    newly-issued 8.75% Senior Secured Second Lien Notes due 2030 (described in Note 20 of the Condensed Consolidated Financial Statements);
    •actively negotiating with our current lender under the Credit Facility to extend the maturity date of the Credit Facility; and
    •actively in discussions with certain parties to further divest non-core assets. We cannot provide any assurances that such transaction will close or that proceeds will not be more or less than we anticipate.

    There is no assurance that we will successfully obtain the financing necessary to satisfy our current obligations when they come due. In addition, we may take one or more of the following actions to obtain the required funding for future operations:

    •Suspension of dividends on our Preferred Stock; and
    •Selling additional common shares.

    Management believes we are taking all prudent actions to address our liquidity concerns; however, these plans have not been finalized and are subject to market conditions that are not within our control. Therefore, we have determined that there is substantial doubt about our ability to continue as a going concern for the 12 months following the issuance of these financial statements.

    The Condensed Consolidated Financial Statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
    Operations

    Our operations are assessed based on three reportable segments as described in Note 4.

    For financial information about our segments, see Note 4 to the Condensed Consolidated Financial Statements.

    NOTE 2 – LOSS PER SHARE

    The following table sets forth the computation of basic and diluted loss per share of our common stock, net of non-controlling interest and dividends on preferred stock:

    Three Months Ended March 31,
    (in thousands, except per share amounts)20252024
    Net loss from continuing operations
    $(7,763)$(12,795)
    Net loss attributable to non-controlling interest
    (18)(42)
    Less: Dividend on Series A preferred stock3,715 3,714 
    Loss from continuing operations attributable to stockholders of common stock
    (11,496)(16,551)
    Loss from discontinued operations, net of tax
    (14,226)(3,996)
    Net loss attributable to stockholders of common stock
    $(25,722)$(20,547)
    Weighted average shares used to calculate basic and diluted loss per share
    97,930 89,479 
    Basic and diluted loss per share:
    Continuing operations$(0.11)$(0.19)
    Discontinued operations(0.15)(0.04)
    Basic and diluted loss per share
    $(0.26)$(0.23)
    Basic and diluted weighted average shares are the same because we incurred a net loss in the three months ended March 31, 2025 and 2024.
    13



    If we had net income in the three months ended March 31, 2025, diluted shares would have included an additional 0.6 million shares. If we had net income for the three months ended March 31, 2024, we would have had no additional diluted shares.

    We excluded 1.1 million and 2.4 million shares related to stock options from the diluted share calculation for the three months ended March 31, 2025 and 2024, respectively, because their effect would have been anti-dilutive.

    NOTE 3 - ASSETS AND LIABILITIES HELD FOR SALE AND DISCONTINUED OPERATIONS

    Assets Held for Sale

    During 2024, we engaged in a strategy and developed a formalized plan to divest certain non-core businesses to reduce our debt, improve our balance sheet and increase liquidity. As of March 31, 2025, we have divested our BWRS, SPIG and GMAB businesses and have a plan to divest our Vølund business in 2025, as discussed below. Results of operations for these businesses and the financial position of the divested subsidiaries are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.

    During the fourth quarter of 2024, we committed to a plan to sell our Vølund business (formerly part of our B&W Renewable segment) and classified the assets and liabilities of this business as held for sale. In addition, we also determined that the operations of the Vølund business qualified as discontinued operations, as this business was part of the formalized plan. As of March 31, 2025 Vølund still qualifies as discontinued operations. We sold our Vølund business on April 29, 2025, described further in Note 20 of the Condensed Consolidated Financial Statements.

    During the third quarter of 2023, we committed to a plan to sell our B&W Solar business (formerly part of our B&W Renewable segment) and classified the assets and liabilities of this business as held for sale. In addition, we also determined that the operations of the B&W Solar business qualified as a discontinued operation, primarily based upon its significance to our current and historic operating losses. Certain circumstances beyond our control have extended the period required to complete the sale within one year, including market conditions driven by uncertainties surrounding the change in U.S. presidential administrations and related impacts to the solar industry. We initiated actions necessary to respond to these changes by engaging an advisory service provider with specialized industry qualifications. We continue to meet the criteria to account for the B&W Solar business as held for sale and discontinued operations as of March 31, 2025.

    Divestitures

    BWRS

    On June 28, 2024, we, through our B&W PGG Luxembourg Finance Sárl subsidiary, sold all issued and outstanding share capital of our Denmark-based renewable parts and services subsidiary, BWRS, to Hitachi Zosen Inova AG. We received net cash proceeds of $83.5 million and recorded a gain on the sale of the business of $44.9 million. The proceeds were used to reduce outstanding debt and support working capital needs. During the three months ended March 31, 2025 we recorded a gain of $1.0 million as part of the final settlement.

    SPIG and GMAB

    On October 30, 2024, we, through our B&W PGG Luxembourg Finance Sárl subsidiary and Babcock & Wilcox A/S subsidiary, sold the entire issued and outstanding share capital of our Italy-based SPIG and Sweden-based GMAB subsidiaries to Auctus Neptune Holding S.p.A. We received net cash proceeds of $33.7 million and recorded a gain of $14.1 million, solely related to the CTA reclassification. We recorded an impairment of $5.8 million as of September 30, 2024, as the disposal group carrying value exceeded the expected net proceeds from the sale. The proceeds were used to support working capital needs and reduce outstanding debt.

    14


    The following tables summarize the operating results of the disposal groups included in discontinued operations in the Condensed Consolidated Statements of Operations:
    Three Months Ended March 31, 2025
    (in thousands)SolarBWRSVølundTotal
    Revenues$10,042 $— $1,171 $11,213 
    Cost of operations11,850 — 3,813 15,663 
    Selling general and administrative expenses1,487 — 1,800 3,287 
    Research and development costs— — 331 331 
    Impairment of long-lived assets7,833 — — 7,833 
    Total costs and expenses21,170 — 5,944 27,114 
    Operating loss(11,128)— (4,773)(15,901)
    Other (expense) income(227)— 975 748 
    Loss from discontinued operations before tax(11,355)— (3,798)(15,153)
    Expense (benefit) from income taxes— — 87 87 
    Gain on divestiture$— $1,014 $— $1,014 
    (Loss) income from discontinued operations, net of tax$(11,355)$1,014 $(3,885)$(14,226)

    Three Months Ended March 31, 2024
    (in thousands)SolarBWRSSPIGGMABVølundTotal
    Revenues$11,373 $17,517 $16,751 $2,006 $6,994 $54,641 
    Cost of operations10,366 12,963 13,357 1,103 7,268 45,057 
    Selling general and administrative expenses1,734 3,300 2,736 338 3,279 11,387 
    Research and development costs— — 85 20 158 263 
    Loss on asset disposals, net— 6 47 — — 53 
    Total costs and expenses12,100 16,269 16,225 1,461 10,705 56,760 
    Operating (loss) income(727)1,248 526 545 (3,711)(2,119)
    Other (expense) income(265)123 (132)312 (1,527)(1,489)
    (Loss) income from discontinued operations before tax(992)1,371 394 857 (5,238)(3,608)
    Benefit from income taxes— — 211 177 — 388 
    (Loss) income from discontinued operations, net of tax$(992)$1,371 $183 $680 $(5,238)$(3,996)
    15


    The following tables provide the major classes of assets and liabilities of the disposal groups included in assets held for sale and liabilities held for sale in the Condensed Consolidated Balance Sheets:

    March 31, 2025
    (in thousands)SolarVølundTotal
    Cash$526 $1,337 $1,863 
    Accounts receivable – trade, net1,273 6,322 7,595 
    Contracts in progress11,649 8,293 19,942 
    Inventories, net— 2,725 2,725 
    Other current assets59 4,799 4,858 
    Total current assets13,507 23,476 36,983 
    Net property, plant and equipment and finance leases2,935 146 3,081 
    Intangible assets, net— 219 219 
    Right-of-use assets47 1,327 1,374 
    Other assets— 673 673 
    Total noncurrent assets2,982 2,365 5,347 
    Total assets held for sale$16,489 $25,841 $42,330 
    Accounts payable$28,487 $9,363 $37,850 
    Accrued employee benefits39 546 585 
    Advance billings on contracts393 3,739 4,132 
    Accrued warranty expense1,174 809 1,983 
    Operating lease liabilities26 287 313 
    Other accrued liabilities2,282 3,046 5,328 
    Current borrowings447 — 447 
    Total current liabilities32,848 17,790 50,638 
    Borrowings, net of current portion561 — 561 
    Operating lease liabilities, net of current portion22 1,048 1,070 
    Total noncurrent liabilities583 1,048 1,631 
    Total liabilities held for sale$33,431 $18,838 $52,269 
    Reported as:
    Current assets held for sale$16,489 $25,841 $42,330 
    Current liabilities held for sale$33,431 $18,838 $52,269 

    16


    December 31, 2024
    (in thousands)SolarVølundTotal
    Cash$1,255 $2,200 $3,455 
    Accounts receivable – trade, net2,814 7,202 10,016 
    Contracts in progress4,157 10,023 14,180 
    Inventories, net— 2,365 2,365 
    Other current assets90 371 461 
    Total current assets8,316 22,161 30,477 
    Net property, plant and equipment and finance leases3,246 124 3,370 
    Intangible assets, net7,833 211 8,044 
    Right-of-use assets53 1,358 1,411 
    Other assets9 243 252 
    Total noncurrent assets11,141 1,936 13,077 
    Total assets held for sale (1)
    $19,457 $24,097 $43,554 
    Accounts payable$30,365 $5,980 $36,345 
    Accrued employee benefits— 518 518 
    Advance billings on contracts961 5,855 6,816 
    Accrued warranty expense1,176 845 2,021 
    Operating lease liabilities26 288 314 
    Other accrued liabilities4,504 190 4,694 
    Current borrowings511 — 511 
    Total current liabilities37,543 13,676 51,219 
    Borrowings, net of current portion874 — 874 
    Operating lease liabilities, net of current portion29 1,075 1,104 
    Other noncurrent liabilities1,199 — 1,199 
    Total noncurrent liabilities2,102 1,075 3,177 
    Total liabilities held for sale (1)
    $39,645 $14,751 $54,396 
    Reported as:
    Current assets held for sale (1)
    $19,457 $24,097 $43,554 
    Current liabilities held for sale (1)
    $39,645 $14,751 $54,396 
    (1) BWRS, SPIG and GMAB were sold in 2024; therefore, no balances are left to disclose.
    The depreciation, amortization, capital expenditures, and significant operating and investing noncash items of the discontinued operations are as follows:

    Three Months Ended March 31, 2025
    (in thousands)SolarBWRSVølundTotal
    Impairment of long-lived assets7,833 — — 7,833 
    Gain on divestiture— 1,014 — 1,014 
    Purchase of property, plant and equipment(95)— (20)(115)

    17


    Three Months Ended March 31, 2024
    (in thousands)SolarBWRSSPIGGMABVølundTotal
    Depreciation and amortization of long-lived assets$— $479 $887 $1 $42 $1,409 
    Purchase of property, plant and equipment(127)(114)(206)— — (447)

    NOTE 4 – SEGMENT REPORTING

    Our operations are assessed based on three reportable market-facing segments as part of our market-focused organizational approach. Our reportable segments are as follows:

    •Babcock & Wilcox Renewable: The B&W Renewable segment offers technologies for efficient and environmentally sustainable power and heat generation, including waste-to-energy, oxygen-fired biomass-to-energy and black liquor systems for the pulp and paper industry. Our leading waste-to-energy technologies support a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering recyclable metals and reducing emissions.
    •Babcock & Wilcox Environmental: The B&W Environmental segment offers a full suite of emissions control and environmental technology solutions for utility, waste-to-energy, biomass-to-energy, carbon black, and industrial steam generation applications around the world. Our broad experience includes systems for ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control.
    •Babcock & Wilcox Thermal: The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance and field services for plants in the power generation, oil and gas, and industrial sectors. We have an extensive global base of installed equipment for utilities and general industrial applications including refining, petrochemical, food processing, metals and others.

    The CODM assesses each segment's performance by using each segment's Adjusted EBITDA. The CODM considers budget-to-actual and forecast-to-actual variances on a quarterly basis when making decisions about the allocation of operating and capital resources to each segment. Adjusted EBITDA by segment includes all items relating to the businesses; items that apply to B&W as a whole are assigned to Corporate. We do not separately identify or report assets by segment as the CODM does not consider assets by segment to be a critical measure by which performance is measured.

    18


    An analysis of our operations by segment is as follows:
    Three Months Ended March 31,
    (in thousands)20252024
    Revenues:
    B&W Renewable segment
    Parts$20,592 $18,367 
    Projects6,058 5,982 
    Construction1,891 3,109 
    28,541 27,458 
    B&W Environmental segment
    Parts7,010 7,157 
    Projects7,397 19,551 
    14,407 26,708 
    B&W Thermal segment
    Parts64,915 53,643 
    Projects32,116 22,794 
    Construction41,215 33,750 
    138,246 110,187 
    Elimination of intersegment revenues— (65)
    Total Revenue$181,194 $164,288 

    19


    The following tables provide information about our segments, as well as the "Corporate/Other Segment" category and include the reconciliation of Revenue to Adjusted EBITDA to Loss from continuing operations before income tax expense:
    Three Months Ended March 31, 2025
    (in thousands)B&W Renewable segmentB&W Environmental segmentB&W Thermal segmentTotal
    Revenue$28,541 $14,407 $138,246 $181,194 
    Cost of operations20,351 10,255 108,444 139,050 
    General & administrative expense (1)
    3,059 894 9,935 13,888 
    Selling & marketing expense (1)
    2,003 989 7,494 10,486 
    Segment Adjusted EBITDA3,128 2,269 12,373 17,770 
    Corporate/eliminations (2)
    (3,461)
    Interest expense, net(10,935)
    Depreciation & amortization(2,476)
    Impairment of long-lived assets(950)
    Benefit plans, net(753)
    Loss on sales, net
    (8)
    Settlement and related legal recoveries (costs)(64)
    Advisory fees for settlement costs and liquidity planning(492)
    Stock compensation(763)
    Restructuring activities(112)
    Acquisition pursuit and related costs(1,356)
    Product development(1,205)
    Foreign exchange261 
    Letter of credit fees(1,200)
    Other-net303 
    Loss from continuing operations before income tax expense$(5,441)

    20


    Three Months Ended March 31, 2024
    (in thousands)B&W Renewable segmentB&W Environmental segmentB&W Thermal segmentTotal
    Revenue$27,458 $26,708 $110,187 $164,353 
    Cost of operations19,898 20,879 82,696 123,473 
    General & administrative expense (1)
    2,466 2,682 6,895 12,043 
    Selling & marketing expense (1)
    2,452 2,120 7,147 11,719 
    Segment Adjusted EBITDA2,642 1,027 13,449 17,118 
    Corporate/eliminations (2)
    (5,856)
    Interest expense, net(11,896)
    Depreciation & amortization(3,159)
    Benefit plans, net96 
    Settlement and related legal recoveries (costs)4,087 
    Advisory fees for settlement costs and liquidity planning(214)
    Loss on debt extinguishment
    (5,071)
    Stock compensation(1,350)
    Restructuring activities(907)
    Acquisition pursuit and related costs(84)
    Product development(1,619)
    Foreign exchange(716)
    Letter of credit fees(2,282)
    Other-net(35)
    Loss from continuing operations before income tax expense$(11,888)
    (1) General & administrative expense excludes corporate/eliminations of $4.0 million and $6.7 million for the three months ended March 31, 2025 and 2024, respectively. We had no selling & marketing expenses excluded from corporate/eliminations for the three months ended March 31, 2025 and 2024.
    (2) Other corporate expenses include certain R&D expenses and other costs not allocated to our segments.

    NOTE 5 – REVENUE RECOGNITION AND CONTRACTS

    Revenue Recognition

    We generate the vast majority of our revenues from the supply of, and aftermarket services for, steam-generating, environmental and auxiliary equipment.

    A performance obligation is a contractual promise to transfer a distinct product or service to the customer. A contract's transaction price is allocated to each distinct performance obligation and is recognized as revenue when (point in time) or as (over time) the performance obligation is satisfied.

    Revenue from products and services transferred to customers at a point in time, which includes certain aftermarket parts and services, accounted for 22% and 24% of revenue for the three months ended March 31, 2025 and 2024, respectively. Revenue from products and services transferred to customers over time, which primarily relates to customized, engineered solutions and construction services, accounted for 78% and 76% of revenue for the three months ended March 31, 2025 and 2024, respectively.

    Refer to Note 4 to the Condensed Consolidated Financial Statements for further disaggregation of revenue.

    21


    Contract Balances

    The following represents the components of the Contracts in progress and Advance billings on contracts included in the Condensed Consolidated Balance Sheets:
    (in thousands)March 31, 2025December 31, 2024$ Change% Change
    Contract assets - included in contracts in progress:
    Costs incurred less costs of revenue recognized$25,734 $31,691 $(5,957)(19)%
    Revenues recognized less billings to customers39,912 50,712 (10,800)(21)%
    Contracts in progress$65,646 $82,403 $(16,757)(20)%
    Contract liabilities - included in advance billings on contracts:
    Billings to customers less revenues recognized$53,636 $57,893 $(4,257)(7)%
    Costs of revenue recognized less cost incurred — 585 (585)(100)%
    Advance billings on contracts$53,636 $58,478 $(4,842)(8)%
    Accrued contract losses$(17)$217 $(234)(108)%

    (in thousands)March 31, 2024December 31, 2023$ Change% Change
    Contract assets - included in contracts in progress:
    Costs incurred less costs of revenue recognized$27,993 $12,100 $15,893 131 %
    Revenues recognized less billings to customers60,000 38,206 21,794 57 %
    Contracts in progress$87,993 $50,306 $37,687 75 %
    Contract liabilities - included in advance billings on contracts:
    Billings to customers less revenues recognized$56,509 $54,051 $2,458 5 %
    Costs of revenue recognized less cost incurred 6,468 5,066 1,402 28 %
    Advance billings on contracts$62,977 $59,117 $3,860 7 %
    Accrued contract losses$(28)$46 $(74)(161)%

    At December 31, 2023, Accounts receivable - trade, net was $101.4 million.

    Backlog

    At March 31, 2025 we had $526.8 million of remaining performance obligations, which we also refer to as total backlog. We expect to recognize approximately 64%, 34% and 2% of the remaining performance obligations as revenue in 2025, 2026 and thereafter, respectively.

    NOTE 6 – INVENTORIES, NET

    Inventories are stated at the lower of cost or net realizable value. Certain raw material inventory is sold to our customers directly and without further processing. The components of Inventories, net included in the Condensed Consolidated Balance Sheets are as follows:
    (in thousands)March 31, 2025December 31, 2024
    Raw materials and supplies$84,853 $87,262 
    Work in progress7,847 6,707 
    Finished goods18,785 14,920 
    Total inventories, net$111,485 $108,889 
    22



    NOTE 7 – PROPERTY, PLANT & EQUIPMENT & FINANCE LEASES

    The following table indicates the carrying value of land and each of the major classes of depreciable assets in the Condensed Consolidated Balance Sheets:
    (in thousands)March 31, 2025December 31, 2024
    Land$1,493 $1,493 
    Buildings24,459 24,244 
    Machinery and equipment125,805 123,678 
    Property under construction17,019 14,466 
    168,776 163,881 
    Less accumulated depreciation120,705 118,869 
    Net property, plant and equipment48,071 45,012 
    Finance leases33,852 34,920 
    Less finance lease accumulated amortization10,752 10,339 
    Net property, plant and equipment, and finance leases$71,171 $69,593 

    NOTE 8 – GOODWILL

    Goodwill represents the excess of the consideration transferred over the fair value of net assets, including identifiable intangible assets, at the acquisition date. Goodwill is assessed for impairment annually on October 1 or more frequently if events or changes in circumstances indicate a potential impairment exists.

    There were no indicators of goodwill impairment identified for the quarter ended March 31, 2025.

    The following summarizes the changes in the net carrying amount of goodwill in the Condensed Consolidated Balance Sheets:
    (in thousands)B&W
    Renewable
    B&W EnvironmentalB&W
    Thermal
    Total
    Balance at December 31, 2024
    $8,482 $5,100 $68,556 $82,138 
    Currency translation adjustments62 62 233 357 
    Balance at March 31, 2025$8,544 $5,162 $68,789 $82,495 



    23


    NOTE 9 – INTANGIBLE ASSETS, NET

    Intangible assets are as follows:
    (in thousands)March 31, 2025December 31, 2024
    Definite-lived intangible assets
    Customer relationships$25,592 $25,462 
    Unpatented technology3,728 3,703 
    Patented technology2,150 1,912 
    Tradename1,797 1,898 
    All other4,369 4,369 
    Gross value of definite-lived intangible assets37,636 37,344 
    Customer relationships amortization(12,463)(11,717)
    Unpatented technology amortization(1,206)(1,129)
    Patented technology amortization(1,229)(1,158)
    Tradename amortization(1,256)(1,224)
    All other amortization(4,369)(4,370)
    Accumulated amortization(20,523)(19,598)
    Net definite-lived intangible assets $17,113 $17,746 
    Indefinite-lived intangible assets
    Trademarks and trade names$1,305 $1,305 
    Total intangible assets, net$18,418 $19,051 


    The following summarizes the changes in the carrying amount of intangible assets, net:
    (in thousands)March 31, 2025
    Balance at beginning of period $19,051 
    Amortization expense(742)
    Currency translation adjustments109 
    Balance at end of the period$18,418 

    Amortization of intangible assets is included in Cost of operations and SG&A in the Condensed Consolidated Statement of Operations.

    Estimated future intangible asset amortization expense as of March 31, 2025 is as follows:
    (in thousands)Amortization Expense
    Year ending December 31, 2025
    2,022 
    Year ending December 31, 2026
    2,674 
    Year ending December 31, 2027
    2,674 
    Year ending December 31, 2028
    2,674 
    Year ending December 31, 2029
    2,660 
    Thereafter4,409 

    24


    NOTE 10 – ACCRUED WARRANTY EXPENSE

    We may offer assurance-type warranties on products and services sold to customers. Changes in the carrying amount of accrued warranty expense are as follows:
    Three Months Ended March 31,
    (in thousands)20252024
    Balance at beginning of period$3,446 $4,380 
    Additions534 439 
    Expirations and other changes(579)(374)
    Payments(24)(411)
    Translation and other18 (20)
    Balance at end of period$3,395 $4,014 

    We record estimated expense included in Cost of operations in the Condensed Consolidated Statements of Operations to satisfy contractual warranty requirements when we recognize the associated revenues on the related contracts, or in the case of a loss contract, the full amount of the estimated warranty costs is recognized when the contract becomes a loss contract. In addition, we record specific adjustments when we expect the actual warranty costs to significantly differ from the initial estimates. Factors that impact our estimate of warranty costs include prior history of warranty claims and our estimate of future costs of materials and labor. Such changes could have a material effect on our consolidated financial position, results of operations and cash flows.
    NOTE 11 – PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

    Components of net periodic benefit cost (benefit) included in net loss are as follows:
    Pension BenefitsOther Benefits
    Three Months Ended March 31,Three Months Ended March 31,
    (in thousands)2025202420252024
    Interest cost$10,224 $10,808 $63 $70 
    Expected return on plan assets(9,683)(11,200)— — 
    Amortization of prior service cost78 53 71 173 
    Benefit plans, net (1)
    619 (339)134 243 
    Service cost included in COS (2)
    195 171 5 4 
    Net periodic benefit cost (benefit)$814 $(168)$139 $247 
    (1) Benefit plans, net, which is presented separately in the Condensed Consolidated Statements of Operations, is not allocated to the segments.
    (2) Service cost related to a small group of active participants is presented within Cost of operations in the Condensed Consolidated Statements of Operations and is recorded at the B&W Thermal segment level.

    There were no MTM adjustments for the pension and other postretirement benefit plans during the three months ended March 31, 2025 and 2024.

    We made contributions to the pension and other postretirement benefit plans totaling $3.7 million and $0.3 million during the three months ended March 31, 2025 and 2024, respectively.

    NOTE 12 – DEBT AND CREDIT FACILITIES

    25


    Senior Notes

    The components of our senior notes at March 31, 2025 are as follows:
    Senior Notes
    (in thousands)
    8.125% (1)
    6.50% (2)
    Total
    Senior notes due in 2026
    $193,035 $151,440 $344,475 
    Unamortized deferred financing costs(1,307)(2,417)(3,724)
    Unamortized premium132 — 132 
    Net debt balance$191,860 $149,023 $340,883 

    The components of senior notes outstanding at December 31, 2024 are as follows:
    Senior Notes
    (in thousands)
    8.125% (1)
    6.50% (2)
    Total
    Senior notes due in 2026
    $193,035 $151,440 $344,475 
    Unamortized deferred financing costs(1,659)(2,757)(4,416)
    Unamortized premium168 — 168 
    Net debt balance$191,544 $148,683 $340,227 
    (1) The 8.125% Senior Notes mature in February 2026 and $108.4 million is included in current liabilities and $83.5 million is included in noncurrent liabilities in the Condensed Consolidated Balance Sheet at March 31, 2025. $191.5 million is included in noncurrent liabilities in the Condensed Consolidated Balance Sheets at December 31, 2024.
    (2) The 6.50% Senior Notes mature in December 2026 and are included in noncurrent liabilities in the Condensed Consolidated Balance Sheet at March 31, 2025 and December 31, 2024.

    Credit Agreement with Axos

    We entered into the Credit Agreement in January 2024, with certain of our subsidiaries as guarantors, the lenders party thereto from time to time and Axos, as administrative agent, swingline lender and letter of credit issuer.

    The Credit Agreement provides for an up to $150.0 million asset-based Credit Facility, including a $100.0 million letter of credit sublimit. Our obligations under the Credit Agreement are guaranteed by certain of our domestic and foreign subsidiaries. B. Riley has provided a guaranty of payment with regard to our obligations under the Credit Agreement, as further described below. We used and expect to use the proceeds and letter of credit availability under the Credit Agreement to (i) provide for working capital needs, (ii) provide cash collateral to secure letters of credit to be issued under the Credit Agreement, and (iii) provide for general corporate purposes.

    The Credit Agreement has a maturity date of January 18, 2027, provided that if as of November 28, 2025, as amended by the Fourth Amendment, the 8.125% Senior Notes and 6.50% Senior Notes have not been refinanced pursuant to a permitted refinancing, as defined in the Credit Agreement, or the maturity date has not otherwise been extended to a date on or after July 18, 2027, then the maturity date of the Credit Agreement is November 28, 2025. As discussed further in Note 1 under Liquidity and Going Concern, we have classified amounts due under the Credit Agreement in current liabilities in the Condensed Consolidated Balance Sheet at March 31, 2025.

    The interest rates applicable under the Credit Agreement are: (i) with respect to SOFR Loans, (a) SOFR plus 5.25% if the outstanding principal amount of loans is equal to or less than $100.0 million or (b) SOFR plus 4.00% if the outstanding principal amount of loans is equal to or greater than $100.0 million; (ii) with respect to Base Rate Loans, the greater of (a) the Federal Funds Rate plus 2.00% plus the Applicable Margin, (b) the prime rate as designated by Axos plus the Applicable Margin, and (c) Daily Simple SOFR plus 1.00% plus the Applicable Margin; and (iii) with respect to the default rate under the Credit Agreement, the then-existing interest rate plus 2.00%.

    In connection with the Credit Agreement, we are required to pay (i) a commitment fee equal to 0.50% per annum multiplied by the positive difference by which the Aggregate Revolving Commitments exceed the Total Revolvings Outstanding (as defined in the Credit Agreement), subject to adjustment, (ii) a facility fee equal to the Applicable Margin for SOFR Loans multiplied by the positive difference by which the actual daily amount of L/C Obligations the Administrative Agent is then holding Specified Cash Collateral exceeds the actual daily Outstanding Amount of Revolving Loans, and (iii) a collateral
    26


    monitoring fee of $1,000 per month. We are permitted to prepay all or any portion of the loans under the Credit Agreement prior to maturity, subject to the payment of an early termination fee. The Credit Agreement requires mandatory prepayments under certain circumstances, including in the event of an overadvance.

    The Credit Agreement also contains customary events of default (subject, in certain instances, to specified grace periods) including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal under the Credit Agreement, the failure to comply with certain covenants and agreements specified in the Credit Agreement, defaults in respect of certain other indebtedness, and certain events of insolvency. If any event of default occurs, Axos may declare the principal, premium, if any, interest and any other monetary obligations on all the then outstanding amounts under the Credit Agreement as due and payable immediately. At March 31, 2025, after giving consideration to the Fifth Amendment ("Fifth Amendment") and Sixth Amendment ("Sixth Amendment") to the Credit Agreement (discussed below), we are in compliance with all financial and other covenants contained in the Credit Agreement.

    On February 28, 2025, the Company with certain subsidiaries of the Company as guarantors, the lenders party to the Credit Agreement and Axos, as administrative agent, entered into the Waiver and Fifth Amendment to the Credit Agreement (the "Fifth Amendment"). In addition, in connection with the Fifth Amendment, the PBGC, Axos, and the second lien holder entered into a lien subordination agreement governing, among other things, the subordination of liens, the provision of enforcement rights, and the application of proceeds.

    On March 25, 2025, the Company with certain subsidiaries of the Company as guarantors, the lenders party to the Credit Agreement and Axos, as administrative agent, entered into the Sixth Amendment to the Credit Agreement. The Sixth Amendment, among other things: (i) authorizes 2025 Specified Dispositions subject to satisfaction of the conditions under the Credit Agreement; (ii) increased the inventory valuation percentage as part of the Borrowing Base calculation; (iii) lowered the minimum liquidity covenant level to $20.0 million; and (iv) acknowledged that the Annual Report's financial statements may be qualified with a going concern opinion for the year ended December 31, 2024.

    At March 31, 2025, we had a total of $123.4 million outstanding on the Credit Agreement, which includes $45.0 million drawn on the revolving credit portion of the facility and $78.4 million drawn on the letter of credit portion. At March 31, 2025, cash collateralizing the letters of credit totaling $78.4 million is classified as current Restricted cash given the classification of the Credit Agreement as current.

    Total Loans Payable

    As of March 31, 2025, we had loans payable, which includes the total outstanding on the Credit Agreement as described above, of $132.7 million, net of debt issuance costs of $0.5 million. Included in these amounts is approximately $9.3 million, net of debt issuance costs of $0.5 million, related to sale-leaseback financing transactions.

    As of December 31, 2024, we had loans payable of $133.7 million, net of debt issuance costs of $0.5 million. Included in these amounts we had approximately $9.3 million, net of debt issuance costs of $0.5 million, related to sale-leaseback financing transactions.

    Revolving and Letter of Credit Agreements

    In June 2021, we entered into the Revolving Credit Agreement with PNC as administrative agent, and the Letter of Credit Agreement, pursuant to which PNC agreed to issue up to $110.0 million in letters of credit that were secured in part by cash collateral provided by MSD, as well as a reimbursement, guaranty and security agreement with MSD, as administrative agent, and the cash collateral providers from time to time party thereto, along with certain of our subsidiaries as guarantors, pursuant to which we are obligated to reimburse MSD and any other cash collateral provider to the extent the cash collateral provided by MSD and any other cash collateral provider securing the Letter of Credit Agreement was drawn to satisfy draws on letters of credit (the "Reimbursement Agreement") and the Debt Facilities. Our obligations under the Debt Facilities were guaranteed by certain of our existing and future domestic and foreign subsidiaries. B. Riley, a related party, provided a guaranty of payment with regard to our obligations under the Reimbursement Agreement. The Debt Facilities were effectively replaced by our Credit Agreement with Axos began in January 2024. The Revolving Credit Agreement with PNC was terminated in connection with our entry into the Credit Agreement and we transitioned letters of credit outstanding under the Letter of Credit Agreement and Reimbursement Agreement to the Credit Agreement. All outstanding letters of credit were transitioned to the Credit Agreement by September 30, 2024, and the Letter of Credit Agreement and Reimbursement Agreement were terminated at that time. We recognized a loss on debt extinguishment of $5.1 million in the three months
    27


    ended March 31, 2024 related to the write-off of unamortized deferred financing fees and other costs incurred to exit the Debt Facilities.

    A summary of usage of letters of credit under the domestic facilities is as follows:

    March 31,
    20252024
    Letters of credit under domestic facilities:
    Performance letters of credit$23,259 $18,155 
    Financial letters of credit12,416 11,511 
    Total outstanding$35,675 $29,666 
    Backstopped letters of credit$750 $750 
    Surety backstopped letters of credit$11,800 $8,742 
    Letters of credit subject to currency revaluation$4,535 $4,390 

    Other Letters of credit, bank guarantees and surety bonds


    Certain of our subsidiaries, that are primarily outside of the United States, have credit arrangements with various commercial banks and other financial institutions for the issuance of letters of credit and bank guarantees in association with contracting activity.

    We have posted surety bonds to support contractual obligations to customers relating to certain contracts. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion. These bonds generally indemnify customers should we fail to perform our obligations under our applicable contracts. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds the underwriters issue in support of some of our contracting activity.

    The following table provides a summary of outstanding letters of credit issued outside of the domestic facilities and outstanding surety bonds:

    March 31,
    20252024
    Letters of credit under non-domestic facilities$2,907 $4,085 
    Surety Bonds $177,426 $146,838 
    Our ability to obtain and maintain sufficient capacity under our current Debt Facilities is essential to allow us to support the issuance of letters of credit, bank guarantees and surety bonds. Without sufficient capacity, our ability to support contract security requirements in the future will be diminished.

    28


    Interest expense in the Condensed Consolidated Financial Statements consisted of the following components:

    Three Months Ended March 31,
    (in thousands)20252024
    Components associated with borrowings from:
    Senior notes$6,320 $6,271 
    Revolving Credit Agreement1,168 1,532 
    7,488 7,803 
    Components associated with amortization or accretion of:
    Revolving Credit Agreement1,609 1,149 
    Senior notes656 644 
    2,265 1,793 
    Components associated with interest from:
    Lease liabilities591 548 
    Letter of Credit interest and fees452 1,489 
    Other interest expense367 381 
    1,410 2,418 
    Total interest expense$11,163 $12,014 

    NOTE 13 – CAPITAL STOCK

    Preferred Stock

    During the three months ending March 31, 2025, our Board of Directors approved dividends totaling $3.7 million to holders of the Preferred Stock. There were no cumulative undeclared dividends of the Preferred Stock at March 31, 2025, and all declared dividends have been paid as of March 31, 2025.

    Common Stock

    On April 10, 2024, we entered into the Sales Agreement with the Agents, in connection with the offer and sale from time to time of shares of our common stock, having an aggregate offering price of up to $50.0 million through the Agents. As of March 31, 2025, 3.3 million shares have been sold pursuant to the Sales Agreement, for net proceeds of $5.2 million.

    On July 11, 2024, we entered into the Registration Rights Agreement with B. Riley. Pursuant to the Registration Rights Agreement, we have agreed to provide B. Riley with customary demand registration rights for all shares of our common stock they beneficially own, including any common stock issuable upon the exercise of any warrants that may be issued to them under the B. Riley Fee Agreement, as described in Note 18 to the Condensed Consolidated Financial Statements.

    29


    NOTE 14 – SUPPLEMENTAL CASH FLOW INFORMATION

    The following table provides a reconciliation of Cash and cash equivalents and Current and Long-term restricted cash reporting within the Condensed Consolidated Balance Sheets and in the Condensed Consolidated Statements of Cash Flows:
    (in thousands)March 31, 2025December 31, 2024
    Held by foreign entities$16,298 $20,790 
    Held by U.S. entities 7,193 6,065 
    Cash and cash equivalents23,491 26,855 
    Reinsurance reserve requirements1,747 2,024 
    Project indemnity collateral4,769 12,878 
    Letters of credit collateral (1)
    78,474 89,265 
    Escrow for long-term project10,138 42 
    Current and Long-term restricted cash and cash equivalents
    95,128 104,209 
    Total Cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows (2)
    $118,619 $131,064 
    (1) Balance drawn on Axos Credit Agreement to serve as collateral on our letters of credit. This is reflected in Current restricted cash in the Condensed Consolidated Balance Sheets.
    (2) Includes cash held at discontinued operations of $1.9 million and $3.5 million at March 31, 2025 and December 31, 2024, respectively.

    NOTE 15 – INCOME TAXES

    In the three months ended March 31, 2025, income tax expense from continuing operations was $2.3 million, resulting in an effective tax rate of (42.7)%. In the three months ended March 31, 2024, income tax expense from continuing operations was $0.9 million, resulting in an effective tax rate of (7.6)%.

    The effective tax rate for the three months ended March 31, 2025 is not reflective of the U.S. statutory rate due to certain foreign countries having a tax rate higher than the U.S. statutory rate, valuation allowances against certain net deferred tax assets and unfavorable discrete items.

    We are subject to federal income tax in the United States and numerous countries that have statutory tax rates different than the U.S. federal statutory rate of 21%. We provide for income taxes based on the tax laws and rates in the jurisdictions where we conduct operations. These jurisdictions may have regimes of taxation that vary in both nominal rates and the basis on which these rates are applied. Our consolidated effective income tax rate can vary from period to period due to these foreign income tax rate variations, changes in the jurisdictional mix of our income, and valuation allowances.

    NOTE 16 – ACCUMULATED OTHER COMPREHENSIVE LOSS

    Gains and losses deferred in AOCI are generally reclassified and recognized in the Condensed Consolidated Statements of Operations once they are realized. The changes in the components of AOCI, net of tax, for the three months ended March 31, 2025 and 2024 were as follows:

    (in thousands)Currency translation lossNet unrecognized loss related to benefit plans (net of tax)Total
    Balance at December 31, 2024$(85,487)$(1,173)$(86,660)
    Other comprehensive income before reclassifications
    403 — 403 
    Reclassification of AOCI to net income
    — 124 124 
    Net other comprehensive income
    403 124 527 
    Balance at March 31, 2025$(85,084)$(1,049)$(86,133)
    30


    (in thousands)Currency translation
    loss
    Net unrecognized loss
    related to benefit plans
    (net of tax)
    Total
    Balance at December 31, 2023$(64,778)$(1,583)$(66,361)
    Other comprehensive loss before reclassifications
    (3,125)— (3,125)
    Reclassification of AOCI to net income
    — 231 231 
    Net other comprehensive (loss) income
    (3,125)231 (2,894)
    Balance at March 31, 2024$(67,903)$(1,352)$(69,255)

    The amounts reclassified out of AOCI by component and the affected Condensed Consolidated Statements of Operations line items are as follows (in thousands):
    AOCI componentLine items in the Condensed Consolidated Statements of Operations affected by reclassifications from AOCI Three Months Ended March 31,
    20252024
    Pension and post retirement adjustments, net of taxBenefit plans, net(124)(231)
    Net loss
    $(124)$(231)

    NOTE 17 – FAIR VALUE MEASUREMENTS

    The following tables summarize financial assets carried at fair value, all of which were valued from readily available prices (known as "Level 1" in the fair value hierarchy established by ASC 820, Fair Value Measurements and Disclosures).

    Securities
    (in thousands)March 31, 2025Level 1
    Corporate notes and bonds$5,117 $5,117 
    United States Government and agency securities1,752 1,752 
    Total fair value of securities$6,869 $6,869 

    (in thousands)December 31, 2024Level 1
    Corporate notes and bonds$5,196 $5,196 
    United States Government and agency securities1,598 1,598 
    Total fair value of securities$6,794 $6,794 

    Investments in securities are presented as $4.5 million in Other current assets and $2.4 million in Other assets as of March 31, 2025 in the Condensed Consolidated Balance Sheets with contractual maturities ranging from 0-5 years.

    Senior Notes

    See Note 12 above in the Condensed Consolidated Financial Statements for a discussion of our senior notes. The fair value of the senior notes is based on readily available quoted market prices (known as "Level 1") as of March 31, 2025:

    (in thousands)March 31, 2025
    Senior NotesCarrying ValueEstimated Fair Value
    8.125% Senior Notes due 2026 ("BWSN")
    $193,035 $163,308 
    6.50% Senior Notes due 2026 ("BWNB")
    $151,440 $112,247 
    31


    Other Financial Instruments

    We used the following methods and assumptions in estimating fair value amounts for other financial instruments:

    •Cash and cash equivalents and restricted cash and cash equivalents. The carrying amounts reported in the accompanying Condensed Consolidated Balance Sheets for cash and cash equivalents and restricted cash and cash equivalents approximate their fair value due to their highly liquid nature and classified as Level 1.
    •Revolving Debt. We base the fair value of debt instruments on quoted market prices. Where quoted prices are not available, we base the fair value on Level 2 inputs such as the present value of future cash flows discounted at estimated borrowing rates for similar debt instruments or on estimated prices based on current yields for debt issues of similar quality and terms. The fair value of Revolving Debt was calculated at $121.1 million which is $2.3 million less than its carrying amount at March 31, 2025.

    NOTE 18 – RELATED PARTY TRANSACTIONS

    Transactions with B. Riley

    Based on Schedule 13D filings with the SEC, B. Riley beneficially owns approximately 29.3% of our outstanding common stock as of March 31, 2025. B. Riley currently has the right to nominate one member of our Board of Directors pursuant to the investor rights agreement we entered into with B. Riley in April 2019. The investor rights agreement also provides pre-emptive rights to B. Riley with respect to certain future issuances of our equity securities.

    As described in Note 12, in connection with our entry into the Axos Credit Agreement in January 2024, we entered into a guaranty agreement (the "B. Riley Guaranty") and a fee and reimbursement agreement (the "B. Riley Fee Agreement") with B. Riley. The B. Riley Guaranty provides for the guarantee of all of our obligations under the Credit Agreement. The B. Riley Guaranty is enforceable in certain circumstances, including, among others, certain events of default and the acceleration of our obligations under the Credit Agreement. The B. Riley Fee Agreement provides, among other things, for us to pay an annual fee to B. Riley equal to 2.00% of Aggregate Revolving Commitments under the Credit Agreement (or approximately $3 million) as consideration for B. Riley's agreements and commitments under the B. Riley Guaranty. The B. Riley Fee Agreement also requires us to reimburse B. Riley to the extent that B. Riley Guaranty is called upon by the agent or lenders under the Credit Agreement and requires us to execute a junior secured promissory note with respect to the same within 60 days after the execution of the B. Riley Fee Agreement (or such other date as B. Riley may agree to).

    As described in Note 13, in April 2024, we entered into a sales agreement with B. Riley Securities, Inc., among others, in connection with the offer and sale from time to time of shares of our common stock. B. Riley will be entitled to compensation equal to 3.0% of the gross proceeds from each sale of the shares sold through it as the designated Agent.

    We entered into an agreement with BRPI Executive Consulting, LLC, an affiliate of B. Riley, in November 2018 and amended the agreement in November 2020 and December 2023 to retain the services of Mr. Kenneth Young to serve as our Chief Executive Officer until December 31, 2028, unless terminated by either party with thirty days written notice. Under this agreement, payments are $0.75 million per annum, paid monthly. Subject to the achievement of certain performance objectives as determined by the Compensation Committee of our Board of Directors, a bonus or bonuses may also be earned and payable to BRPI Executive Consulting, LLC. In September 2024, we came to an agreement with BRPI Executive Consulting, LLC to terminate the agreement to retain the services of Mr. Kenneth Young effective immediately and concurrently entered into a direct arrangement with Mr. Kenneth Young. We paid nothing and $0.2 million in the three months ended March 31, 2025 and 2024, respectively, to BRPI Executive Consulting, LLC.

    We entered into an Advisory Services Agreement with B. Riley on December 12, 2024 to provide financial advisory services to the Company relating to the Company's evaluation of debt financing alternatives. Under this agreement, payments are a cash fee equal to 1.75% of the total financing value, due and payable immediately upon the closing of each debt financing.

    Transactions with Board of Directors

    We entered into a Consultant Agreement with Henry E. Bartoli, a member of our Board of Directors, dated November 5, 2020. On November 26, 2024, we entered into a third amendment to the Bartoli Consulting Agreement that extends the term through December 1, 2025, subject to earlier termination by either party as provided in the Bartoli Consulting Agreement.
    32



    NOTE 19 – NEW ACCOUNTING PRONOUNCEMENTS AND STANDARDS

    The Company did not adopt any new accounting pronouncements during the three months ended March 31, 2025.

    New accounting standards to be adopted

    We consider the applicability and impact of all issued ASUs. Certain recently issued ASUs were assessed and determined to not be applicable. New accounting standards not yet adopted that could affect the Condensed Consolidated Financial Statements in the future are summarized as follows:

    In October 2023, FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative ("ASU 2023-06"). The new guidance is intended to align GAAP and SEC requirements while facilitating the application of GAAP for all entities. The effective date of ASU 2023-06 depends on (1) whether an entity is already subject to the SEC's current disclosure requirements and (2) whether and, if so, when the SEC removed related requirements from its regulations. For entities that are already subject to the SEC's current disclosure requirements, the effective date for each amendment will be the date on which the SEC's removal of that related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. If the SEC has not removed the related requirements from its regulations by June 30, 2027, the amendments made by ASU 2023-06 will be removed from the Codification and will not become effective for any entity. The impact of this standard on the Company's Condensed Consolidated Financial Statements is contingent upon future transactions.

    In December 2023, FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires disclosure of specific categories in the effective tax rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The standard is intended to benefit investors by providing more detailed income tax disclosures to assess how an entity's operations and related tax risks, tax planning and operational opportunities affect its tax rate and prospects for future cash flows. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. Adoption of the standard, applied retrospectively, will only impact the income tax disclosures and is not expected to be material to the Condensed Consolidated Financial Statements.

    In November 2024, FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). The new guidance is intended to improve financial reporting by requiring all public business entities to disclose additional information about specific expense categories. ASU 2024-03 is effective for annual periods beginning after December 15, 2026. Early adoption is permitted. Further, in January 2025, FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2025-01 is clarifying the effective dates outlined in ASU 2024-03 which is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027, applied retrospectively. We are currently evaluating the impact of this standard on the Condensed Consolidated Financial Statements.

    NOTE 20 – SUBSEQUENT EVENTS

    Divestiture

    On April 29, 2025, Babcock & Wilcox A/S (“BWAS”), a subsidiary of Babcock & Wilcox Enterprises, Inc. (the “Company”), sold a majority of its assets, including intellectual property, specific project contracts as well as related agreements with suppliers and certain tangible assets, to Kanadevia Inova Denmark A/S (the “Buyer”). The sale was comprised of a simultaneous transfer of assets from BWAS to a newly incorporated BWAS subsidiary (the “NewCo”) pursuant to a business transfer agreement (“BTA”), and sale of NewCo by BWAS to the Buyer pursuant to a share purchase agreement (the “SPA” and together with the BTA, the “Purchase Agreements”).

    The Purchase Agreements provide for a base purchase price equal to $15.0 million plus 400,000 Danish krone, subject to certain offsets and adjustments, including additional payments to BWAS if the Buyer enters into certain prospective project agreement within five years. In addition, BWAS and the Buyer entered into an agreement under which Buyer loaned BWAS $5.0 million which will be considered repaid when BWAS transfers to NewCo certain retained intellectual property usage rights. The Purchase Agreements also include representations and warranties regarding BWAS and the transferred business and assets, as well as certain indemnities with respect thereto.
    33



    BWAS and the Buyer entered into a transition services agreement under which BWAS and/or its affiliates will provide services to support the NewCo for a temporary period. BWAS also entered into an intellectual property rights license agreement, a subcontractor agreement, and a legacy contract services agreement in connection with the Purchase Agreements. In addition, the Company’s subsidiary, The Babcock & Wilcox Company, entered into two memorandums of understanding with the Buyer related to future cooperation in connection with the sale.

    The Company does not have any material relationship with the Buyer other than in respect of the transaction. The proceeds will be used to support working capital needs and reduce outstanding debt.

    Senior Notes Refinancing

    On May 8, 2025, we entered into privately negotiated exchanges with a limited number of noteholders (the "Exchanges") that will result in $47.8 million aggregate principal amount of the Company's 6.50% Senior Notes due 2026 and $84.0 million aggregate principal amount of the Company's 8.125% Senior Notes due 2026 being exchanged for $100.8 million aggregate principal amount of newly-issued 8.75% Senior Secured Second Lien Notes due 2030 (the "New Notes"). Consummation of the Exchanges is subject to customary closing conditions.
    34



    Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

    The following discussion of our financial position and results of operations should be read in conjunction with the financial statements and the notes thereto included in the Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements as a result of many factors, including those described in more detail under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024. See also "Cautionary Statement Concerning Forward-Looking Information" herein. Unless otherwise noted, discussion of our business and results of operations refers to our continuing operations.

    BUSINESS OVERVIEW

    We are a globally-focused renewable, environmental and thermal technologies provider with over 155 years of experience providing diversified energy and emissions control solutions to a broad range of industrial, electrical utility, municipal and other customers. Our innovative products and services are organized into three market-facing segments. Our reportable segments are as follows:

    •Babcock & Wilcox Renewable: Our innovative BrightLoop™ hydrogen generation technology supports global climate goals including the decarbonization of industrial and utility steam and power producers. BrightLoop™ offers significant advantages over other hydrogen generation technologies as it generates competitively priced hydrogen from a wide range of fuels, including solid fuels such as biomass and coal, with a high rate of carbon captured resulting in low, or even negative, carbon-intensity hydrogen. We also offer best-in-class technologies for efficient and environmentally sustainable power and heat generation, oxygen-fired biomass-to-energy (OxyBright™), and black liquor systems for the pulp and paper industry. Our leading waste-to-energy technologies support a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering recyclable metals and reducing emissions.
    •Babcock & Wilcox Environmental: We provide a full suite of emissions control and environmental technology solutions for utility, waste-to-energy, biomass-to-energy, carbon black, and industrial steam generation applications around the world. Our broad experience includes systems for ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control and mercury control. Our ClimateBright™ products including SolveBright™, OxyBright™, BrightLoop™ and BrightGen™ place us at the forefront of hydrogen production and decarbonization technologies and development with many of these products already commercially available and others ready for commercial deployment. We believe these technologies position us to compete in the bioenergy sector within the carbon capture and sequestration (BECCS) market. Our portfolio of clean power production solutions continues to evolve to reach customers at all stages of their energy transition.
    •Babcock & Wilcox Thermal: Our vast installed base of steam generation equipment includes aftermarket parts, construction, maintenance and field services for plants in the power generation, oil and gas and industrial sectors. We have an extensive global base of installed equipment for utilities and general industrial applications including refining, petrochemical, food processing, metals and others. We provide aftermarket parts, construction, maintenance, engineered upgrades and field services for our installed base as well as the installed base of other original equipment manufacturers; the substantial and stable cash flows generated from these businesses help to fund our investments in new clean energy initiatives. In addition to our aftermarket offerings, we also provide complete steam generation systems including package boilers, watertube and firetube waste heat boilers, and other boilers to medium and heavy industrial customers. Our unique range of offerings, coupled with the strength of our brand, provides a competitive advantage in existing and emerging markets.

    Market Update

    Management continues to adapt to macroeconomic conditions, including the impacts from inflation, higher interest rates and foreign exchange rate volatility, current and potential tariff actions and geopolitical conflicts. In certain instances, these situations have resulted in cost increases and delays or disruptions that have had, and could continue to have, an adverse impact on our ability to meet customers’ demands. We continue to actively monitor the impact of these market conditions on current and future periods and actively manage costs and our liquidity position to provide additional flexibility while still supporting our customers and their specific needs. The duration and scope of these conditions cannot be predicted, and therefore, any anticipated negative financial impact on our operating results cannot be reasonably estimated.

    35


    Discontinued Operations

    Vølund

    During the fourth quarter of 2024, we committed to a plan to sell our Vølund business, resulting in a significant change that would impact our business. As of March 31, 2025, we met all of the criteria for the assets and liabilities of this business, formerly part of our B&W Renewable segment, to be accounted for as held for sale.

    For the three months ended March 31, 2025, revenue decreased to $1.2 million from $7.0 million in the three months ended March 31, 2024, primarily as a result of several larger projects that had higher volumes of work in 2024 than in 2025. Operating loss for the three months ended March 31, 2025 was $4.8 million, which is slightly higher than the Operating loss of $3.7 million for the three months ended March 31, 2024 as a result of the aforementioned reduction of revenue due to the lack of larger projects to replace the larger volume of work in 2024.

    B&W Solar

    During the third quarter of 2023, we committed to a plan to sell our B&W Solar business, resulting in a significant change that would impact our operations. As of September 30, 2023, we met all of the criteria for the assets and liabilities of this business, formerly part of our B&W Renewable segment, to be accounted for as held for sale. In addition, we also determined that the operations of the B&W Solar business qualified as a discontinued operation, primarily based upon its significance to our current and historic operating losses.

    Certain circumstances beyond our control have extended the period required to complete the sale within one year, including market conditions driven by uncertainties surrounding the change in U.S. presidential administrations and related impacts to the solar industry. We initiated actions necessary to respond to these changes by engaging an advisory service provider with specialized industry qualifications. We continue to meet the criteria to account for the B&W Solar business as held for sale and discontinued operations as of March 31, 2025.

    For the three months ended March 31, 2025, revenue decreased to $10.0 million from $11.4 million in the three months ended March 31, 2024 as a result of significantly less work year over year. Operating loss for the three months ended March 31, 2025 increased to $11.1 million from $0.7 million in the three months ended March 31, 2024, primarily as a result of an impairment of intangible asset and the decrease in revenue as mentioned above.

    BWRS, SPIG and GMAB

    In addition to the B&W Solar and Vølund businesses, discontinued operations include the following subsidiaries divested in 2024: BWRS, SPIG, and GMAB. These sale transactions were part of a previously announced strategy to divest certain non-core businesses to reduce our debt, improve our balance sheet and increase liquidity. Results of operations and cash flows for these businesses and the financial position of the divested subsidiaries are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.

    RESULTS OF OPERATIONS

    Components of Our Results of Operations

    Revenue

    Revenue is the total amount of income generated by our business and consists primarily of income from the renewable, environmental and thermal technology solutions and services we provide to a broad range of industrial, electric utility and other customers. Revenue from our operations is assessed based on our three market-facing segments, B&W Renewable, B&W Environmental and B&W Thermal.

    Operating income

    Operating income consists primarily of revenue minus costs and expenses, including cost of operations, SG&A, and advisory fees and settlement costs.
    36



    Net loss

    Net loss consists primarily of operating (loss) income minus other income and expenses, including interest income, foreign exchange and expense related to our benefit plans, and provision for income taxes.

    Consolidated Results of Operations

    The following discussion of our consolidated and business segment results of operations includes a discussion of Adjusted EBITDA, which, when used on a consolidated basis, is a non-GAAP financial measure. Adjusted EBITDA differs from net loss, the most directly comparable measure calculated in accordance with GAAP. Management believes that this financial measure is useful to investors because it excludes certain expenses, allowing investors to more easily compare our operating performance period to period. A reconciliation of net loss to Adjusted EBITDA is included in "Non-GAAP Financial Measures" below.

    Three Months Ended March 31,
    (in thousands)20252024$ Change
    Revenues:
    B&W Renewable segment
    Parts$20,592 $18,367 $2,225 
    Projects6,058 5,982 76 
    Construction1,891 3,109 (1,218)
    28,541 27,458 1,083 
    B&W Environmental segment
    Parts7,010 7,157 (147)
    Projects7,397 19,551 (12,154)
    14,407 26,708 (12,301)
    B&W Thermal segment
    Parts64,915 53,643 11,272 
    Projects32,116 22,794 9,322 
    Construction41,215 33,750 7,465 
    138,246 110,187 28,059 
    Eliminations of intersegment revenues— (65)65 
    Total Revenue$181,194 $164,288 $16,906 
    Operating income
    $5,850 $5,722 $128 
    Loss from continuing operations
    $(7,763)$(12,795)$5,032 

    Three months ended March 31, 2025 and 2024

    Revenues increased by $16.9 million to $181.2 million in the three months ended March 31, 2025 as compared to $164.3 million in the three months ended March 31, 2024. The increase was primarily driven by activity related to a large natural gas project of $8.5 million, higher construction volume of $6.0 million and an increase in parts sales of $10.0 million. These were partially offset by projects that were worked off in 2024 but not fully replaced in the first quarter of 2025.

    Operating income for the three months ended March 31, 2025 was $5.9 million as compared to $5.7 million in the three months ended March 31, 2024. Operating income was flat year over year despite the aforementioned revenue growth due to
    37


    increased cost of operations associated with the revenue growth as well as impairment and losses on disposal of approximately $1.0 million and slight increases in SG&A expenses.

    Loss from continuing operations decreased by $5.0 million to $7.8 million in the three months ended March 31, 2025 as compared to $12.8 million in the three months ended March 31, 2024. The decrease was primarily driven by the $5.1 million loss on debt extinguishment from the prior year as the remaining deferred financing fees associated with the terminated PNC Revolving Credit Agreement were written off.

    Other Expenses Impacting Operating Results

    Interest Expense

    Three Months Ended March 31,
    (in thousands)20252024
    Components associated with borrowings from:
    Senior Notes$6,320 $6,271 
    Revolving Credit Facility1,168 1,532 
    7,488 7,803 
    Components associated with amortization or accretion of:
    Revolving Credit Agreement1,609 1,149 
    Senior Notes656 644 
    2,265 1,793 
    Components associated with interest from:
    Lease liabilities591 548 
    Letter of credit interest and fees452 1,489 
    Other interest expense367 381 
    1,410 2,418 
    Total interest expense$11,163 $12,014 

    Interest expense for the three months ended March 31, 2025 is lower due to the decrease in letter of credit usage in 2025 compared to 2024.

    Income Taxes
    Three Months Ended March 31,
    (in thousands, except for percentages)20252024$ Change
    Loss from continuing operations before income tax expense
    $(5,441)$(11,888)$6,447 
    Income tax expense
    $2,322 $907 $1,415 
    Effective tax rate(42.7)%(7.6)%

    Deferred tax assets are evaluated each period to determine whether realization is more likely than not. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. Valuation allowances may be removed in the future if sufficient positive evidence exists to outweigh the negative evidence under the framework of ASC 740, Income Taxes ("ASC 740").

    Our effective tax rate for the first three months of 2025 is not reflective of the U.S. statutory rate primarily due to certain foreign entities having a tax rate higher than the U.S statutory rate, valuation allowances against certain net deferred tax assets and unfavorable discrete items. In certain jurisdictions where we anticipate a loss for the year or incur a loss for the year-to-date period for which a tax benefit cannot be realized in accordance with ASC 740, we exclude the loss in that jurisdiction from the overall computation of the estimated annual effective tax rate.

    38


    Bookings and Backlog

    Bookings and backlog are our measures of remaining performance obligations under our sales contracts. We believe these metrics provide investors, lenders and other users of our financial statements with a leading indicator of future revenues. It is possible that our methodology for determining bookings and backlog may not be comparable to methods used by other companies.

    We generally include expected revenue from contracts in our backlog when we receive written confirmation from our customers authorizing the performance of work and committing the customers to payment for work performed. Backlog may not be indicative of future operating results, and contracts in our backlog may be canceled, modified or otherwise altered by customers. Backlog can vary significantly from period to period, particularly when large new-build conversion projects or operations and maintenance contracts are booked because they may be fulfilled over multiple years. Because we operate globally, our backlog is also affected by changes in foreign currencies each period.

    Bookings represent changes to the backlog. Bookings include additions related to booking new business or increases in project scope, subtractions due to customer cancellations or reductions in scope, changes in estimates that affect selling price and revaluation of backlog denominated in foreign currency. We believe comparing bookings on a quarterly basis or for periods less than one year is less meaningful than for longer periods, and that shorter-term changes in bookings may not necessarily indicate a material trend.
    Three Months Ended March 31,
    (in approximate millions)20252024
    B&W Renewable$31.7 $34.7 
    B&W Environmental11.1 11.5 
    B&W Thermal124.7 106.5 
    Other/eliminations(0.5)(2.9)
    Bookings$167.0 $149.8 

    Backlog as of March 31, 2025 and 2024 was as follows:
    As of March 31,
    (in approximate millions)20252024
    B&W Renewable$56.7 $67.8 
    B&W Environmental38.7 72.6 
    B&W Thermal424.6 209.1 
    Other/eliminations6.8 9.6 
    Backlog$526.8 $359.1 

    Of the backlog at March 31, 2025, we expect to recognize revenues as follows:
    (in approximate millions)20252026ThereafterTotal
    B&W Renewable$34.0 $21.1 $1.6 $56.7 
    B&W Environmental23.2 14.4 1.1 38.7 
    B&W Thermal271.1 142.9 10.7 424.7 
    Other/eliminations6.7 — — 6.7 
    Expected revenue from backlog$335.0 $178.4 $13.4 $526.8 


    Non-GAAP Financial Measures

    We use non-GAAP financial measures internally to evaluate our performance and make financial and operational decisions. When viewed in conjunction with GAAP results and the accompanying reconciliations, we believe that the presentation of
    39


    these measures provides investors with greater transparency and a greater understanding of factors affecting our financial position and results of operations than GAAP measures alone. The presentation of non-GAAP financial measures should not be considered in isolation or as a substitute for the related financial results prepared in accordance with GAAP.

    The following discussion of our business segment results of operations includes a discussion of EBITDA and Adjusted EBITDA. EBITDA focuses on the earnings generated from core business operations, without considering the effects of financing, accounting decisions or tax. Adjusted EBITDA differs from the most directly comparable measure calculated in accordance with GAAP. A reconciliation of net loss, the most directly comparable GAAP measure, to Adjusted EBITDA is included below. Management believes that this financial measure is useful to investors because it excludes certain expenses, allowing investors to more easily compare our financial performance period to period. When viewed in conjunction with GAAP results and the accompanying reconciliation in Note 4 to the Condensed Consolidated Financial Statements, we believe the presentation of Adjusted EBITDA provides investors with greater transparency and a greater understanding of factors affecting our financial position and results of operations than GAAP measures alone.

    Adjusted EBITDA on a consolidated basis is defined as the sum of the Adjusted EBITDA for each of the segments, further adjusted for corporate allocations and research and development costs. At a segment level, the Adjusted EBITDA metrics presented in this report is consistent with the manner in which our CODM primarily reviews the results of operations and makes strategic decisions about the business. Our CODM is the chief executive officer and on a quarterly basis reviews actuals to budgets and forecasts when making decisions. Adjusted EBITDA is calculated as earnings before interest, tax, depreciation and amortization adjusted for items such as gains or losses arising from the sale of non-income producing assets, net pension benefits, restructuring activities, impairments, gains and losses on debt extinguishment, legal and settlement costs, costs related to financial consulting, research and development costs, and other costs that may not be directly controllable by segment management and are not allocated to the segment. We present consolidated Adjusted EBITDA because we believe it is useful to investors to help facilitate comparisons of the ongoing, operating performance before corporate overhead and other expenses not attributable to the operating performance of our revenue generating segments.

    Three Months Ended March 31,
    (in thousands)20252024
    Net loss
    $(21,989)$(16,791)
    Loss from discontinued operations, net of tax
    (14,226)(3,996)
    Loss from continuing operations
    (7,763)(12,795)
    Interest expense, net10,935 11,896 
    Income tax expense2,322 907 
    Depreciation & amortization2,476 3,159 
    EBITDA7,970 3,167 
    Impairment of long-lived assets950 — 
    Benefit plans, net753 (96)
    Loss on asset disposals, net
    8 — 
    Stock compensation763 1,350 
    Restructuring activities112 907 
    Settlements and related legal costs (recoveries)
    64 (4,087)
    Advisory fees for settlement costs and liquidity planning492 214 
    Loss on debt extinguishment
    — 5,071 
    Acquisition pursuit and related costs1,356 84 
    Product development1,205 1,619 
    Foreign exchange(261)716 
    Letter of credit fees1,200 2,282 
    Other - net(303)35 
    Adjusted EBITDA $14,309 $11,262 
    40




    Three Months Ended March 31,
    (in thousands)20252024
    Adjusted EBITDA
    B&W Renewable $3,128 $2,642 
    B&W Environmental 2,269 1,027 
    B&W Thermal 12,373 13,449 
    Corporate(3,461)(5,856)
    $14,309 $11,262 

    Corporate

    Corporate costs in Adjusted EBITDA include SG&A expenses that are not allocated to the reportable segments. These costs include, among others, certain executive, compliance, strategic, reporting and legal expenses associated with governance of the total organization and being an SEC registrant, and research and development activity costs.

    Impairment of long-lived assets

    Impairment of long-lived assets refers to when the carrying amount of an asset exceeds the fair value or recoverable amount.

    Benefit plans, net

    We recognize benefits from our defined benefit and other postretirement benefit plans based on actuarial calculations primarily because our expected return on assets is greater than our service cost. Service cost is low because our plan benefits are frozen except for a small number of hourly participants.

    Our pension costs include MTM adjustments and are primarily a result of changes in the discount rate, curtailments and settlements. Any MTM charge or gain should not be considered to be representative of future MTM adjustments as such events are not currently predicted and are in each case subject to market conditions and actuarial assumptions as of the date of the event giving rise to the MTM adjustment.

    Refer to Note 11 to the Condensed Consolidated Financial Statements for further information regarding our pension and other postretirement plans.

    Loss on asset disposals, net

    We, at times, will sell or dispose of certain assets that are unrelated to our current or future operations. Therefore, we believe it is useful to exclude these gains and losses from our non-GAAP financial measures in order to highlight the performance of the continuing business.

    Stock compensation

    The grant date fair value of stock compensation varies based on the derived stock price at the time of grant, valuation methodologies, subjective assumptions, and reward types. This may make the impact of this form of compensation on our current financial results difficult to compare to previous and future periods. Therefore, we believe it is useful to exclude stock-based compensation from our non-GAAP financial measures in order to highlight the performance of the business and to be consistent with the way many investors evaluate our performance and compare our operating results to peer companies.

    Restructuring activities

    Restructuring activities and business services transition actions across our business units and corporate functions primarily consist of severance and related costs associated with non-recurring actions taken to transform our operations with impacts on employees and facilities used in our businesses. Business services transition costs relate to new technology implementation,
    41


    expected to provide future benefit and are included in Selling, general and administrative expenses in the Condensed Consolidated Statement of Operations.

    Settlements and related legal costs (recoveries)

    Please refer to our Annual Report on Form 10-K for the year ended December 31, 2024 as there have been no material changes and no new litigation to disclose as of March 31, 2025.

    Advisory fees for settlement costs and liquidity planning

    Advisory fees fluctuate based on use of external consultants.

    Loss on debt extinguishment

    Losses on debt extinguishment were due to the write-off of deferred financing fees and certain other exit costs associated with our extinguishment of the Debt Facilities.

    Acquisition pursuit and related costs

    Acquisition pursuit and related costs fluctuate based on activity.

    Product development

    Our product development activities include expenses that relate to sales, marketing, and other business development expenses for our products and services still under development and not yet widely available and are primarily from the timing of specific research and increased development efforts and activities related to our BrightLoop™ commercialization efforts and to further develop our ClimateBright™ portfolio. Management excludes these expenses from Adjusted EBITDA as they often may not correlate to revenue or other operations occurring in the current period.

    Foreign exchange

    We translate assets and liabilities of our foreign operations into U.S. dollars at current exchange rates, and we translate items in our Condensed Consolidated Statement of Operations at average exchange rates for the periods presented. We record adjustments resulting from the translation of foreign currency amounts as a component of Accumulated Other Comprehensive Loss. We report foreign currency transaction gains (losses) in income in the Condensed Consolidated Statements of Operations. Management excludes these expenses from Adjusted EBITDA as they do not reflect the ordinary course of business and are inherently unpredictable in timing and amount.

    Foreign exchange gains and losses are primarily related to unhedged intercompany loans denominated in European currencies to fund foreign operations.

    Letter of credit fees

    Letter of credit fees are routinely incurred in the course of executing customer contracts. A portion of the fees are included in the contract prices with our customers. Certain letter of credit amounts represent performance guarantees akin to insurance that are not passed along to our customers and are excluded from Adjusted EBITDA as they do not reflect the performance of the business. Letter of credit fees are not passed along to customers and included in Cost of operations in the Condensed Consolidated Statement of Operations.

    RESULTS BY SEGMENT

    42


    B&W Renewable Segment Results
    Three Months Ended March 31,
    (in thousands)20252024$ Change
    Revenues$28,541 $27,458 $1,083 
    Adjusted EBITDA$3,128 $2,642 $486 

    Three months ended March 31, 2025 and 2024

    Revenues in the B&W Renewable segment increased 4%, or $1.1 million, to $28.5 million in the three months ended March 31, 2025 compared to $27.5 million in the three months ended March 31, 2024. This is primarily due to increases in our pulp and paper business.

    Adjusted EBITDA in the B&W Renewable segment increased $0.5 million, to $3.1 million in the three months ended March 31, 2025 compared to $2.6 million in the three months ended March 31, 2024 driven by the revenue volume described above.

    B&W Environmental Segment Results
    Three Months Ended March 31,
    (in thousands)20252024$ Change
    Revenues$14,407 $26,708 $(12,301)
    Adjusted EBITDA$2,269 $1,027 $1,242 

    Three months ended March 31, 2025 and 2024

    Revenues in the B&W Environmental segment decreased 46%, or $12.3 million, to $14.4 million in the three months ended March 31, 2025 compared to $26.7 million in the three months ended March 31, 2024. The decrease is primarily due to larger projects that were worked off in 2024 but not fully replaced in the first quarter of 2025.

    Adjusted EBITDA in the B&W Environmental segment was $2.3 million in the three months ended March 31, 2025 compared to $1.0 million in the three months ended March 31, 2024. The increase is primarily attributable to the lower allocated SG&A expenses due to less revenue.

    B&W Thermal Segment Results
    Three Months Ended March 31,
    (in thousands)20252024$ Change
    Revenues$138,246 $110,187 $28,059 
    Adjusted EBITDA$12,373 $13,449 $(1,076)

    Three months ended March 31, 2025 and 2024

    Revenues in the B&W Thermal segment increased 25%, or $28.1 million, to $138.2 million in the three months ended March 31, 2025 compared to $110.2 million in the three months ended March 31, 2024. The increase is primarily related to revenues from a large natural gas project of $8.5 million, higher construction volume of $6.0 million and an increase in parts of $10.0 million.

    Adjusted EBITDA in the B&W Thermal segment decreased $1.1 million to $12.4 million in the three months ended March 31, 2025 compared to $13.4 million in the three months ended March 31, 2024. The increase is due to the revenue increase described above offset partially by a larger share of allocated SG&A expenses due to the increase in revenue.

    43


    Liquidity and Capital Resources

    Liquidity

    Our primary liquidity requirements include debt service, funding of dividends on preferred stock and working capital needs. We fund our liquidity requirements primarily through cash generated from operations, external sources of financing, including our Credit Agreement, senior notes, and equity offerings, and our Preferred Stock, each of which are described in the Notes to Condensed Consolidated Financial Statements included in Part I, Item I of this Quarterly Report in further detail.

    The Company has a credit agreement that provides for an up to $150.0 million asset-based credit facility with an outstanding balance of $123.4 million at March 31, 2025 that is currently due in November 2025 and, accordingly, is classified as a current liability. In addition, the Company has senior notes due in February 2026 of which $108.4 million is reflected in current liabilities and $83.5 million in noncurrent liabilities in the Condensed Consolidated Balance Sheets. As a result, the uncertainty regarding our ability to repay the current debt raises substantial doubt about our ability to continue as a going concern.

    As of March 31, 2025, 3.3 million shares have been sold pursuant to the Sales Agreement for net proceeds of $5.2 million. Refer to Note 13 to the Condensed Consolidated Financial Statement for additional discussion of the Sales Agreement.

    In response to the conditions that raised substantial doubt and to partially address our liquidity needs, during the three months ended March 31, 2025, we took the following actions, among others:

    •sold our Vølund business on April 29, 2025 for a total of $20.1 million in proceeds, which is comprised of a base purchase price equal to $15.0 million plus 400,000 Danish krone and a $5.0 million loan (described in Note 20 of the Condensed Consolidated Financial Statements);
    •sold 3.3 million and 5.0 million common shares for net proceeds of $5.2 million and $7.9 million as of March 31, 2025 and December 31, 2024, respectively, pursuant to our At-The-Market offering (described in Note 13 to the Condensed Consolidated Financial Statements);
    •actively negotiating with holders of the Senior Notes to extend their maturity date. We have entered into privately negotiated exchanges with a limited number of noteholders that will result in $47.8 million aggregate principal amount of the Company's 6.50% Senior Notes due 2026 and $84.0 million aggregate principal amount of the Company's 8.125% Senior Notes due 2026 being exchanged for $100.8 million aggregate principal amount of newly-issued 8.75% Senior Secured Second Lien Notes due 2030 (described in Note 20 of the Condensed Consolidated Financial Statements);
    •actively negotiating with our current lender under the Credit Facility to extend the maturity date of the Credit Facility; and
    •actively in discussions with certain parties to further divest non-core assets. We cannot provide any assurances that such transaction will close or that proceeds will not be more or less than we anticipate.

    There is no assurance that we will successfully obtain the financing necessary to satisfy our current obligations when they come due. In addition, we may take one or more of the following actions to obtain the required funding for future operations:

    •Suspension of dividends on our Preferred Stock; and
    •Selling additional common shares.

    Management believes it is taking all prudent actions to address its liquidity concerns, however, these plans have not been finalized and are subject to market conditions that are not within the Company's control, therefore we have determined that there is substantial doubt about our ability to continue as a going concern for the 12 months following the issuance of these financial statements.

    Cash and Cash Flows

    At March 31, 2025, our cash and cash equivalents, and restricted cash totaled $118.6 million, and we had total debt of $473.6 million as well as $191.7 million of gross preferred stock outstanding. Our foreign business locations held $16.3 million of our total cash and cash equivalents and restricted cash as of December 31, 2025. In general, our foreign cash balances are not available to fund our U.S. operations unless the funds are repatriated or used to repay intercompany loans made from the U.S. to foreign entities, which could expose us to taxes we have not made a provision for in our results of operations. We have no
    44


    plans to repatriate these funds to the U.S. In addition, we had $78.5 million of restricted cash as of March 31, 2025 related to collateral for certain letters of credit as part of funding for several ongoing projects.

    Cash flows used in operating activities was $8.5 million in the three months ended March 31, 2025, which is primarily attributable to the year-to-date net loss of $22.0 million, partially offset by non-cash expenses arising from impairment of long-lived assets of $8.8 million, depreciation and amortization of long-lived assets of $2.5 million, amortization of deferred financing fees of $1.5 million, and operating lease expenses of $1.7 million. Cash flows used in operating activities also included movements in certain operating assets and liabilities such as accounts receivable trade, net of $(14.3) million, contracts in progress of $11.0 million, and advanced billings on contracts of $(7.5) million which are primarily impacted by timing differences related to progress made on ongoing projects, billings, and collections, and may fluctuate significantly period to period. Operating cash flow increases from accounts payable of $19.6 million and accrued and other current liabilities of $8.9 million is the result of timing of payments to vendors.

    Cash flows used in operating activities was $14.9 million in the three months ended March 31, 2024, which was primarily attributed to the year-to-date net loss of $16.8 million. Non-cash expenses including the loss on the debt extinguishment of $5.1 million, depreciation and amortization of long-lived assets of $4.8 million, deferred taxes of $2.5 million and operating lease expenses of $1.8 million were primarily offset by movements in certain operating assets and liabilities such as accounts receivable - trade, net of $16.8 million, contracts in progress of $(21.5) million, advanced billings on contracts of $(6.4) million, and accrued and other current liabilities of $(8.4) million due to the same factors noted for the first quarter of 2025.

    Cash flows used in investing activities was $3.9 million and $2.8 million in the three months ended March 31, 2025 and 2024, respectively, primarily due to capital expenditures associated with BrightLoop™ projects.

    Cash flows used in financing activities of $0.4 million in the three months ended March 31, 2025 were primarily due to the payment of preferred dividends of $3.7 million and net payments on the Axos Credit Agreement of $1.4 million, partially offset by the issuance of common stock of $5.2 million. Cash flows provided by financing activities of $51.3 million in the three months ended March 31, 2024 were primarily due to net borrowings on the Axos Credit Agreement of $61.6 million, partially offset by the payment of the preferred stock dividend of $3.7 million.

    Debt and Credit Facilities

    As described in Note 12 to our Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report, we entered into a Credit Agreement in January 2024. B. Riley, a related party, has provided a guaranty of payment with regard to our obligations under the Credit Agreement. This agreement substantially replaces the existing Reimbursement Agreement, Revolving Credit Agreement and Letter of Credit Agreement. We completed the transition of letters of credit outstanding under the Letter of Credit Agreement and Reimbursement Agreement to the Credit Agreement in August 2024. Information related to our Debt and Credit Facilities is described in Note 12 to the Condensed Consolidated Financial Statements and is incorporated herein by reference.

    CRITICAL ACCOUNTING POLICIES AND ESTIMATES

    For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited Condensed Consolidated Financial Statements, see "Critical Accounting Policies and Estimates" in our Annual Report on Form 10-K for the year ended December 31, 2024. There have been no significant changes to our policies during the three months ended March 31, 2025 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.

    Item 3. Quantitative and Qualitative Disclosures About Market Risk

    Our exposure to market risks has not changed materially from those disclosed under "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended December 31, 2024.

    Item 4. Controls and Procedures

    Disclosure Controls and Procedures

    As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as
    45


    that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the Securities and Exchange Commission under the Exchange Act.

    Based on this evaluation and because of the previously-reported material weaknesses in internal control over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2025.

    Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of March 31, 2025 were not effective, our management, including our Chief Executive Officer and Chief Financial Officer, has concluded that the Condensed Consolidated Financial Statements as of and for the three months ended March 31, 2025 and 2024 present fairly, in all material respects, our financial position, results of operations and cash flows in conformity with GAAP.

    Remediation Plan and Status

    As of March 31, 2025, the material weaknesses previously disclosed have not yet been remediated. In response to the material weaknesses in our internal control over financial reporting, management has initiated remediation efforts, which includes:
    •continuing to hire qualified accounting professionals;
    •developing and providing additional training to the accounting and financial reporting team;
    •designing and implementing additional and/or enhanced controls in the areas of account reconciliations, contract accounting, financial statement analysis and complex and/or non-routine transactions;
    •enhancing controls over IT user access and segregation of duties; and,
    •developing and implementing a monitoring program to evaluate and assess whether controls are present and functioning appropriately.

    We will continue to work toward full remediation of the material weaknesses to improve our internal control over financial reporting. The material weaknesses will not be considered remediated until the new and redesigned controls operate for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. Accordingly, we will continue to monitor and evaluate the effectiveness of our internal control over financial reporting in the areas affected by the material weaknesses.

    Changes in Internal Control Over Financial Reporting

    There were no changes in internal control over financial reporting (as defined by Rule 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

    Inherent Limitations in Effectiveness of Controls

    Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures, or our internal controls, will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple error or mistake or fraud. Additionally, controls can be circumvented by individuals or groups of persons or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements in our public reports due to error or fraud may occur and not be detected.

    PART II

    46


    Item 1. Legal Proceedings

    Please refer to our Annual Report on Form 10-K for the year ended December 31, 2024 as there have been no material changes and no new litigation to disclose as of March 31, 2025.

    Item 1A. Risk Factors

    We are subject to various risks and uncertainties in the course of our business. The discussion of such risks and uncertainties may be found under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024. There have been no material changes to the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024.

    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

    In accordance with the provisions of the employee benefit plans, we acquire shares in connection with the vesting of employee restricted stock that require us to withhold shares to satisfy employee statutory income tax withholding obligations. During the quarter ended March 31, 2025, we did not have any repurchases of shares related to employee restricted stock plans. Also, we do not have a general share repurchase program at this time.

    Item 5. Other Information

    During the three months ended March 31, 2025, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

    47


    Item 6. Exhibits
    2.1*
    Master Separation Agreement, dated as of June 8, 2015, between The Babcock & Wilcox Company and Babcock & Wilcox Enterprises, Inc. (incorporated by reference to Exhibit 2.1 to the Babcock & Wilcox Enterprises, Inc. Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (File No. 001-36876)).
    3.1
    Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (File No. 001-36876)).
    3.2
    Certificate of Amendment of the Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on June 17, 2019 (File No. 001-36876)).
    3.3
    Certificate of Amendment of the Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on July 24, 2019 (File No. 001-36876)).
    3.4
    Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on May 23, 2023 (File No. 001-36876)).
    3.5
    Amended and Restated Bylaws of Babcock & Wilcox Enterprises, Inc. (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on March 5, 2025 (File No. 001-36876)).
    3.6
    Certificate of Designations with respect to the 7.75% Series A Cumulative Perpetual Preferred Stock, dated May 6, 2021, filed with the Secretary of State of Delaware and effective on May 6, 2021 (incorporated by reference to Exhibit 3.4 to the Babcock & Wilcox Enterprises, Inc. Form 8-A filed on May 7, 2021 (File No. 001-36876)).
    3.7
    Certificate of Increase in Number of Shares of 7.75% Series A Cumulative Perpetual Preferred Stock, dated June 1, 2021 (incorporated by reference to Exhibit 3.1 to the Babcock & Wilcox Enterprises, Inc. Current Report on Form 8-K filed on July 7, 2021 (File No. 001-36876)).
    10.1
    Fifth Amendment to Credit Agreement among Babcock & Wilcox Enterprises, Inc., the lenders and Axos Bank, dated February 28, 2025 (incorporated by reference to Exhibit 10.83 to the Babcock & Wilcox Enterprises, Inc. Annual Report on Form 10-K for the year ended December 31, 2024 (File No. 001-36876)).
    10.2
    Sixth Amendment to Credit Agreement among Babcock & Wilcox Enterprises, Inc., the lenders and Axos Bank, dated March 25, 2025 (incorporated by reference to Exhibit 10.84 to the Babcock & Wilcox Enterprises, Inc. Annual Report on Form 10-K for the year ended December 31, 2024 (File No. 001-36876)).
    10.3*
    Purchase Agreement by and between Babcock & Wilcox A/S and Kanadevia Inova Denmark A/S, filed herewith.
    31.1
    Rule 13a-14(a)/15d-14(a) certification of Chief Executive Officer.
    31.2
    Rule 13a-14(a)/15d-14(a) certification of Chief Financial Officer.
    32.1
    Section 1350 certification of Chief Executive Officer.
    32.2
    Section 1350 certification of Chief Financial Officer.
    101.SCHXBRL Taxonomy Extension Schema Document.
    101.CALXBRL Taxonomy Extension Calculation Linkbase Document.
    101.LABXBRL Taxonomy Extension Label Linkbase Document.
    101.PREXBRL Taxonomy Extension Presentation Linkbase Document.
    101.DEFXBRL Taxonomy Extension Definition Linkbase Document.
    104Cover Page Interactive Data File (embedded within the inline XBRL document)

    *Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.
    48


    SIGNATURES

    Pursuant to the requirements of the Section 13 or 15(d) of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    BABCOCK & WILCOX ENTERPRISES, INC.
    May 12, 2025By:/s/ Cameron Frymyer
    Cameron Frymyer
    Executive Vice President and Chief Financial Officer
    (Principal Financial and Accounting Officer and Duly Authorized Representative)
    49
    Get the next $BW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BW

    DatePrice TargetRatingAnalyst
    4/7/2025$1.00Buy → Neutral
    DA Davidson
    11/10/2023$10.00 → $2.00Buy → Hold
    Craig Hallum
    7/19/2022$11.00Buy
    Craig Hallum
    9/9/2021$0.73 → $6.00Underperform
    Credit Suisse
    More analyst ratings

    $BW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Frymyer Cameron M claimed ownership of 97,370 shares (SEC Form 3)

      3 - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      1/10/25 5:36:31 PM ET
      $BW
      Building Products
      Industrials
    • Amendment: Director Bartoli Henry E was granted 43,353 shares, increasing direct ownership by 13% to 368,366 units (SEC Form 4)

      4/A - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      1/7/25 4:33:28 PM ET
      $BW
      Building Products
      Industrials
    • Director Bartoli Henry E was granted 75,000 shares, increasing direct ownership by 23% to 400,013 units (SEC Form 4)

      4 - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      1/3/25 4:32:51 PM ET
      $BW
      Building Products
      Industrials

    $BW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Moeller Philip D bought $22,000 worth of shares (20,000 units at $1.10), increasing direct ownership by 30% to 85,774 units (SEC Form 4)

      4 - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      3/22/24 8:04:09 AM ET
      $BW
      Building Products
      Industrials
    • Salamone Louis Jr bought $4,080 worth of shares (4,000 units at $1.02), increasing direct ownership by 0.63% to 636,711 units (SEC Form 4)

      4 - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      3/22/24 8:01:59 AM ET
      $BW
      Building Products
      Industrials
    • Young Kenneth M bought $30,001 worth of shares (29,229 units at $1.03) (SEC Form 4)

      4 - Babcock & Wilcox Enterprises, Inc. (0001630805) (Issuer)

      3/22/24 8:00:15 AM ET
      $BW
      Building Products
      Industrials

    $BW
    SEC Filings

    See more
    • Babcock & Wilcox Enterprises Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Babcock & Wilcox Enterprises, Inc. (0001630805) (Filer)

      5/12/25 4:42:58 PM ET
      $BW
      Building Products
      Industrials
    • SEC Form 10-Q filed by Babcock & Wilcox Enterprises Inc.

      10-Q - Babcock & Wilcox Enterprises, Inc. (0001630805) (Filer)

      5/12/25 4:40:34 PM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Enterprises Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Babcock & Wilcox Enterprises, Inc. (0001630805) (Filer)

      5/12/25 6:34:29 AM ET
      $BW
      Building Products
      Industrials

    $BW
    Financials

    Live finance-specific insights

    See more
    • Babcock & Wilcox Enterprises Reports First Quarter 2025 Results

      Announced a bond exchange of $131.8 million of bonds into $100.8 million of new five-year second lien notes Revenue of $181.2 million and Operating Income of $5.9 million exceeded expectations Adjusted EBITDA of $14.3 million significantly outperformed expectations Achieved the highest Q1 bookings, revenue, gross profit and EBITDA for Global Parts & Service on record Announced Bookings from Continuing Operations of $167.0 million, an 11% increase compared to the same period of 2024 Continuing Operations Backlog of $526.8 million in the first quarter, a 47% increase compared to the same period of 2024 Announced sale of assets of Denmark-based A/S subsidiary for $20 million

      5/12/25 4:30:00 PM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Sets First Quarter 2025 Conference Call and Webcast for Monday, May 12, 2025 at 5 p.m. ET

      Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, May 12, 2025 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's first quarter 2025 results. A news release detailing the results is expected to be issued after the market closes on the day of the conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the dial-

      5/8/25 6:30:00 AM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Enterprises Reports Fourth Quarter and Full Year 2024 Results

      Revenue from Continuing Operations in Q4 2024 of $200.8 million increased 15% Year over Year Operating Income from Continuing Operations in Q4 2024 of $11.6 million increased $14.8 million compared to Q4 2023 Announced Full Year 2024 Bookings from Continuing Operations of $889.6 million, a 39% increase compared to the same period of 2023 Announced Continuing Operations Backlog of $540.1 million, a 47% increase compared to the same period of 2023 Progressed BrightLoop™ project in Massillon, Ohio, and maintaining target to produce hydrogen and sequester CO2 by early 2026 Anticipate positive net cash flow in 2025 excluding BrightLoop Awarded $10.0 million of support from state of

      3/31/25 5:00:00 PM ET
      $BW
      Building Products
      Industrials

    $BW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Babcock & Wilcox Enterprises Reports First Quarter 2025 Results

      Announced a bond exchange of $131.8 million of bonds into $100.8 million of new five-year second lien notes Revenue of $181.2 million and Operating Income of $5.9 million exceeded expectations Adjusted EBITDA of $14.3 million significantly outperformed expectations Achieved the highest Q1 bookings, revenue, gross profit and EBITDA for Global Parts & Service on record Announced Bookings from Continuing Operations of $167.0 million, an 11% increase compared to the same period of 2024 Continuing Operations Backlog of $526.8 million in the first quarter, a 47% increase compared to the same period of 2024 Announced sale of assets of Denmark-based A/S subsidiary for $20 million

      5/12/25 4:30:00 PM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Announces Private Bond Exchanges to Reduce Outstanding Debt, Lower Annual Interest Expense and Extend Debt Maturity to 2030

      Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE:BW) announced it has entered into privately negotiated exchanges with a limited number of noteholders (the "Exchanges") that will result in $131.8 million of the Company's outstanding Senior Notes due 2026 being exchanged for $100.8 million in newly issued 8.75% Senior Secured Second Lien Notes due 2030 (the "New Notes"). The Exchanges will include approximately $84 million in 8.125% Senior Notes due February 28, 2026 and approximately $48 million in 6.50% Senior Notes due December 31, 2026. Total interest expense will be reduced by $1.1 million annually. The Exchanges are subject to customary closing conditions. The offer a

      5/12/25 6:30:00 AM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Sets First Quarter 2025 Conference Call and Webcast for Monday, May 12, 2025 at 5 p.m. ET

      Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, May 12, 2025 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's first quarter 2025 results. A news release detailing the results is expected to be issued after the market closes on the day of the conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the dial-

      5/8/25 6:30:00 AM ET
      $BW
      Building Products
      Industrials

    $BW
    Leadership Updates

    Live Leadership Updates

    See more
    • Babcock & Wilcox Announces Leadership Appointments

      - Lou Salamone to retire as Chief Financial Officer - Cameron Frymyer named Chief Financial Officer - Chris Riker named Chief Operating Officer - Jimmy Morgan named Chief Commercial Officer - Gillianne Hetrick named Senior Vice President, Corporate Operations Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE:BW) announced the following leadership changes that will become effective January 1, 2025. Lou Salamone, who has served as Chief Financial Officer since November 2018, has announced he will retire from his role. In connection with his transition from his current position, Mr. Salamone has entered into an agreement with the Company to provide consulting servic

      12/2/24 4:48:00 PM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Enterprises, Inc. Appoints Dr. Naomi Boness (Ph.D.) to Board of Directors

      As Managing Director of the Natural Gas Initiative at Stanford University and Co-Managing Director of the Stanford Hydrogen Initiative, Dr. Boness brings extensive expertise in hydrogen and energy Babcock & Wilcox Enterprises, Inc. (B&W) (NYSE:BW) announced today that Dr. Naomi Boness (Ph.D.) has been appointed to its Board of Directors, increasing the size of the Board to seven members. Dr. Boness is the Managing Director of the Natural Gas Initiative at Stanford University and Co-Managing Director of the Stanford Hydrogen Initiative. An experienced energy sector expert, she is focused on using her background in reservoir geophysics and technoeconomic modeling to develop technology sol

      11/14/23 6:30:00 AM ET
      $BW
      Building Products
      Industrials

    $BW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Babcock & Wilcox Enterprises Inc.

      SC 13G - Babcock & Wilcox Enterprises, Inc. (0001630805) (Subject)

      9/30/24 5:12:59 PM ET
      $BW
      Building Products
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Babcock & Wilcox Enterprises Inc.

      SC 13D/A - Babcock & Wilcox Enterprises, Inc. (0001630805) (Subject)

      9/25/24 5:00:02 PM ET
      $BW
      Building Products
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Babcock & Wilcox Enterprises Inc.

      SC 13D/A - Babcock & Wilcox Enterprises, Inc. (0001630805) (Subject)

      7/15/24 5:15:02 PM ET
      $BW
      Building Products
      Industrials

    $BW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Babcock & Wilcox Enterprises downgraded by DA Davidson with a new price target

      DA Davidson downgraded Babcock & Wilcox Enterprises from Buy to Neutral and set a new price target of $1.00

      4/7/25 11:53:52 AM ET
      $BW
      Building Products
      Industrials
    • Babcock & Wilcox Enterprises downgraded by Craig Hallum with a new price target

      Craig Hallum downgraded Babcock & Wilcox Enterprises from Buy to Hold and set a new price target of $2.00 from $10.00 previously

      11/10/23 7:25:47 AM ET
      $BW
      Building Products
      Industrials
    • Craig Hallum initiated coverage on Babcock & Wilcox Enterprises with a new price target

      Craig Hallum initiated coverage of Babcock & Wilcox Enterprises with a rating of Buy and set a new price target of $11.00

      7/19/22 9:07:51 AM ET
      $BW
      Building Products
      Industrials